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Abstract 
Isometric handgrip (IHG) exercise training is an effective method of blood pressure (BP) 
reduction in clinical and non-clinical populations. The efficacy of IHG on cardiovagal 
baroreflex sensitivity (cvBRS) and systemic arterial stiffness (i.e. carotid-toe pulse wave 
velocity (ctPWV)) is less well understood, especially in hypertensive populations who 
demonstrate increased arterial stiffness and decreased BRS. Furthermore, hypertension is 
considered an accelerated model of cognitive decline, often attributed to the effects of 
increased BP and arterial stiffness. This study utilized IHG (n=8) and CON groups (n=4) 
to examine the effects of 8-weeks of IHG training or no IHG training on arterial stiffness, 
cvBRS, and cognitive function in hypertensive adults. Significant group differences in SBP 
and ctPWV change was observed (p<0.05) indicating that IHG training reduced SBP and 
systemic arterial stiffness compared to no IHG training. Moreover, although not significant 
(p>0.05), the IHG group demonstrated an ~53% increase in BRS. Lastly, a significant 
difference in Trail Making Test Part A (TMT-A) time (p<0.001) was observed in the IHG 
group, suggesting that IHG training improved motor, and visual control and speed. These 
findings suggest that IHG training can improve systemic arterial stiffness and possibly 
cvBRS in a hypertensive population, in addition to the new potential for improving specific 
aspects of cognitive function. 
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1 Chapter 1: Introduction 
1.1 Study Rationale 
Hypertension (resting manual arterial blood pressure (BP) ≥ 140/90 mmHg, although new 
guidelines exist regarding hypertension classification using automated devices is 135/85 
mmHg) is now considered the leading risk factor for death in the world.1,2 Incidence of 
hypertension is projected to affect 1.56 billion adults by the year 2025.3 Conventional 
treatment strategies include lifestyle and pharmacological interventions which target BP 
reduction.4  
 Hypertension is associated with adverse changes in multiple measures of 
cardiovascular health such as carotid-femoral pulse wave velocity (cfPWV), arterial 
distensibility, heart rate variability (HRV) and cardiovagal baroreflex sensitivity 
(cvBRS).5–7 Importantly, progression of arterial stiffening seen in hypertension is believed 
to contribute to damage in the microvasculature of the brain, which functionally manifests 
as reduced cognitive function.8–13 BP and cognition have been found to demonstrate an 
inverse linear relationship, such that individuals with higher BP have greater cognitive 
impairment compared to those with lower BP.14 Isometric handgrip (IHG) exercise training 
has been shown to improve resting BP and has potential to also improve arterial stiffness 
and autonomic function.15 These prospective improvements in cardiovascular health may 
also attenuate or reverse deleterious effects on cognition associated with hypertension.16 
 Investigation into IHG training, a simple and effective BP reduction tool, has shown 
promising effects on several indices of cardiovascular health.15 IHG training generally 
requires individuals to hold a low intensity static contraction (30% of maximum) for four 
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2-minute bouts, on three days per week, for a period of 8-10 weeks. This regimen 
consistently shows high adherence rates and significant BP lowering effects in a diverse 
range of populations, while requiring a lower time commitment in comparison to traditional 
exercise strategies.15 Most importantly, IHG training reduces BP in medicated hypertensive 
adults.17–19 However, little is known regarding additional effects of IHG training on 
secondary indices of cardiovascular health apart from decreased BP.15 Hypothesized 
improvements included increased cardiovagal baroreflex sensitivity (cvBRS), reduced 
arterial stiffness (PWV, common carotid artery (CCA) distensibility) and, ultimately, 
improved cognitive function. As such, IHG exercise is a promising intervention with 
potential for improving the above factors which influence cognitive function and will be 
investigated in the present study. 
1.2 Objectives 
This study aimed to investigate several objectives surrounding cardiovascular and 
cognitive health in hypertensive adults.  
1. To determine the effects of 8-weeks of IHG training on markers of arterial 
health and stiffness (i.e. BP, CCA distensibility, ctPWV, crPWV).  
2. To determine the effects of 8-weeks of IHG training on measures of cardiac 
autonomic function (i.e. cvBRS, HRV).  
3. To examine adaptations in assessments of cognitive function following 8-weeks 
of IHG training. 
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2 Chapter 2: Literature Review 
2.1 Blood Pressure 
Arterial BP refers to the pressure exerted against arterial walls and transiently rises and 
falls to meet the demands of the cardiovascular system in order to maintain a homeostatic 
environment.20 Arterial BP is influenced by a combination of arterial blood volume and 
arterial compliance which is further affected by cardiac output (CO) and total peripheral 
resistance (TPR).21 Systolic blood pressure (SBP) is defined as the outward pressure 
against the arterial wall when blood is ejected from the left ventricle and through the arterial 
system, whereas diastolic blood pressure (DBP) is defined as the arterial pressure during 
ventricular relaxation.22 Mean arterial pressure (MAP), represents the mean oscillating 
point at which BP varies during any given cardiac cycle.21 Pulse pressure (PP), the 
consequence of intermittent ventricular ejection, is simply calculated as the difference 
between SBP and DBP.21–23 Additionally, TPR is calculated as the ratio between MAP and 
CO and represents the resistance to flow in the arterial system.21 
 Early epidemiologic studies pointed towards DBP as a stronger predictor for 
cardiovascular disease severity than SBP, until a paper from the Framingham Heart Study 
showed SBP was associated with complications linked to hypertension.24,25 However, even 
more recently, epidemiologic investigations suggest that SBP is superior to DBP for 
predicting risk of stroke and ischemic heart disease, as elevations in SBP are associated 
with increased TPR.24,26,27 In addition to SBP as a cardiovascular disease risk predictor, PP 
has emerged as an independent marker of cardiovascular risk and is strongly associated 
with cognitive impairment in hypertensive populations.8,23,28 
4 
 
 In clinical practice, resting BP is most commonly measured via auscultation which 
requires a mercury sphygmomanometer and stethoscope placed around the upper arm and 
over the brachial artery respectively.29,30 The mercury sphygmomanometer is manually 
inflated to 30 mmHg above the point of disappearance of the brachial pulse and slowly 
released at a rate of 2 mmHg/second or 2 mmHg per beat if the suspected heart rate (HR) 
is ≤ 60 bpm.29 SBP is recorded as the point where pulsations are first heard upon cuff 
deflation.29,30 DBP determination requires more expertise on behalf of the clinician and is 
recorded at the point where pulsations disappear and/or the last sound heard upon cuff 
deflation.29  
 While the auscultation method of assessing resting BP is most common, it has been 
shown to elicit a "white-coat" effect in some patients.31 This effect describes a clinically 
meaningful difference between out-of-office and office BP in treated hypertensive 
individuals.31 When the difference between office and out-of-office BP is ≥ 20 mmHg SBP 
and/or ≥ 10 mmHg DBP, white-coat hypertension is believed to be present.32 White-coat 
hypertension has been shown to be minimized in situations where physicians have minimal 
involvement in the BP measurement.32 As such, automated BP measuring devices have 
become increasingly common in clinical practice, often replacing the mercury 
sphygmomanometer altogether. Which is why automated BP measuring devices are now 
commonly used to assess hypertension status over the mercury sphygmomanometer and 
have a slightly lower classification value of 135/85 mmHg due to the inherent lower 
measured values observed with this method.2  
Automated BP measuring devices rely upon internal algorithms which detect small 
pressure oscillations.33  It is interesting to note that the oscillometric method of determining 
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BP actually pre-dates auscultation as it was first introduced in 1876 by Marey.34 
Unfortunately, the oscillometric method was ahead of its time as the technology required 
to accurately incorporate this method into clinical practice was not in place until the 1970s 
and 1980s when microprocessors and miniature electronic pressure sensors were developed 
to validate and automate measurements against gold standard measurements using intra-
arterial pressures and auscultation.33 These automated oscillometric devices calculate BP 
by measuring a series of small pressure pulses while the cuff pressure is consequently 
increased and decreased.33 Furthermore, the amplitude of these oscillations is used to 
determine the SBP and DBP respectively.33  
Automated BP aims to reduce the three most common errors associated with resting 
BP measurement: 1) patient related (i.e. stress associated with clinic visit) 2) observer error 
and 3) observer-patient interaction.32 The white-coat effect typically observed during 
regular office BP measurement is almost completely abolished by use of an automated BP 
device.35 When automated BP was introduced into the primary care of individuals with 
predominantly isolated systolic hypertension and receiving antihypertensive therapy, SBP 
was decreased within a range of 9-13 mmHg compared with auscultation.35 
 Automated BP devices  provide an effective alternative to manual BP in that 
measurement is less affected by the environment (e.g. office vs. home), they provide 
similar information to awake ABPM devices, and they reduce the white-coat effect as 
previously mentioned.32 In addition to the above recommendations for automated BP, 
circumstances where testing occurs at multiple sites and the same technician is unable to 
attend all sessions lend itself to the use of automated BP devices to reduce variation across 
sites.32 
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2.1.1 Hypertension 
Hypertension, or chronically elevated BP, is diagnosed as the average of two resting BP 
measurements ≥ 140/90 mmHg when measured on at least two separate occasions by a 
sphygmomanometer.36,37 Recent literature suggests when measuring and classifying BP 
using an automated BP device, a lower cut-off for hypertension of 135/85 is required.2 An 
estimated 29.2% of individuals 20 years and older are projected to have hypertension by 
the year 2025; a 4% increase from the year 2000.3 Furthermore, the estimated total number 
of adults living with hypertension is projected to increase by 60% from the years 2000 to 
2025.3 Of these individuals expected to develop hypertension over the coming decade, 
increases of 24% and 80% are predicted to occur in economically developed and 
developing nations respectively.3 A recent study found that high BP has overtaken 
childhood malnutrition, unsafe water consumption, sanitation and hand-washing as the 
leading individual risk factor for death in the world.1 Accordingly, hypertension is now 
widely regarded as a global health concern.3 
 Hypertension is associated with numerous adverse health-related outcomes 
including increased risk of cardiovascular disease such as stroke, heart failure, chronic 
kidney disease, and peripheral artery disease.4 Hypertension is considered to be one of 
several modifiable risk factors for cardiovascular disease including sedentary lifestyle, 
smoking, diabetes, high cholesterol, physical inactivity and overweight/obesity.38 The 
precise etiology of hypertension is unknown in approximately 90-95% of all cases and is 
referred to as essential hypertension.37 
 Traditional anti-hypertensive treatments involve a combination of lifestyle and 
pharmacological interventions. Lifestyle interventions include weight management, 
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reduction in dietary salt and alcohol intake, and increased physical activity.39 Some of the 
most commonly prescribed anti-hypertensive medications include diuretics, beta blockers, 
angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), 
calcium channel blockers (CCBs), and vasodilators. Briefly, diuretics promote increased 
secretion of water from the body through prevention of sodium reabsorption, thereby 
reducing blood volume and BP.40 Beta blockers are competitive antagonists which block 
norepinephrine and epinephrine receptor sites which result in decreased HR and CO, 
inducing a concomitant decrease in BP.40 ACE inhibitors induce relaxation of vascular 
smooth muscle in arterial walls by blocking the conversion of angiotensin I to angiotensin 
II, thereby lowering arterial resistance and venous capacity, decreasing CO and therefore 
BP.41 ARBs prevent angiotensin II from binding to angiotensin II receptors on vascular 
smooth muscle, thus allowing the artery wall to dilate and result in BP reduction. CCBs 
block calcium inflow through channels in the vascular smooth muscle and myocardium, 
thus increasing coronary dilation, decreasing myocardial contractility, and decreasing 
peripheral resistance.40 Vasodilators induce BP reduction via a reduction in sympathetic 
tone to vascular smooth muscle.40 While the mechanism of action of each medication is 
variable, the goal is generally to provide a stimulus which reduces vasoconstriction, or the 
degree of activation of the vascular smooth muscle cells within the arterial walls. Multiple 
classes of anti-hypertensive medication are often utilized as nearly two-thirds of 
hypertensives are unable to control resting BP to within clinical target ranges using a single 
anti-hypertensive medication.42 
Anti-hypertensive medication is effective in only 53% of hypertensive individuals.43 
This may be a result of poor adherence to medication regiments, perhaps due to side-effects 
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associated with medications. Non-adherence to anti-hypertensive medication is associated 
with worse BP control and adherence usually declines over time with an estimated 42% of 
newly diagnosed hypertensive individuals ceasing to continue with their medication within 
1 year of starting treatment.44,45 Aerobic and resistance exercise are often recommended as 
a method of BP reduction however, not knowing how or what to do and lack of motivation 
are often cited as barriers preventing individuals from participating in exercise to observe 
these adaptations.46 Thus a simple, time efficient and effective method of BP reduction is 
warranted to help combat the low rates of hypertension control. 
2.2 Arterial Stiffness  
The cardiovascular system is comprised of the heart, arteries, and veins, and is responsible 
for distributing blood throughout the body to meet metabolic demands. The arterial system 
functions as a conduit which transports oxygenated blood and dampens pulsatile flow 
generated through the intermittent ejection of blood from the heart.47 One of the most 
clinically relevant arteries is the aorta which, in healthy individuals, is capable of 
significant levels of distension to propagate pulse waves distally along the vessel 
length.48,49 
 Each segment of the arterial system is comprised of elastin, collagen, and vascular 
smooth muscle. Elastin provides reversible extensibility during mechanical loading and 
unloading of arteries throughout the stages of the cardiac cycle, whereas collagen prevents 
arterial wall failure at high pressures.50 Vascular smooth muscle minimally influences 
behaviour of large elastic arteries such as the aorta, but in peripheral resistance arteries, 
vascular smooth muscle cells are primarily responsible for spontaneous vasomotor changes 
in diameter and stiffness.51–53 This, in addition to greater collagen concentrations in small 
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peripheral arteries, contributes to increased peripheral arterial stiffness in comparison to 
the central arteries.49,52  
 Arterial composition is not homogenous throughout the arterial tree in that central 
arteries contain higher elastin levels compared to peripheral arteries.23,54 Likewise, this 
concentration is not static throughout the lifespan and across the BP spectrum.49 As elastin 
is broken down due to aging or BP induced adaptations, increased collagen is deposited to 
maintain the structural integrity of the arterial wall, thus resulting in a shift of the arterial 
mechanical properties towards increased stiffness.23,49  
2.2.1 Central Pulse Wave Velocity 
Stiffness of the large central arteries (i.e. aorta) is most commonly measured using the gold 
standard carotid-femoral pulse wave velocity (cfPWV).48 cfPWV measures the speed at 
which a pressure waveform propagates along a segment of the arterial tree; the stiffer the 
vessel, the greater the PWV. It is calculated as:48 
𝑃𝑊𝑉 =  ∆𝐷/∆𝑇 
where ΔD is the distance (metres) between measurement sites and ΔT represents the pulse 
wave transit time (PWTT) (seconds).48 
 When blood is ejected from the left ventricle of the heart, a pressure wave is 
generated against the arterial wall which travels at a given PWV along the arterial tree in 
direct proportion to the elastic properties of that vessel segment. In healthy arterial systems, 
the pulse wave propagates at a lower velocity due to pulsatile energy being stored in the 
elastic arterial wall to a greater extent than in older individuals and those with hypertension 
whom have stiffer arteries.7 Progressively higher BP is associated with increased PWV at 
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any age (Figure 2.1). It is impossible to extrapolate segmental arterial properties to the 
entire arterial tree as no segment has identical viscoelastic properties and concentrations of 
elastin, collagen, and vascular smooth muscle; thus greatly influencing the PWV of any 
given artery.48 
 The most clinically relevant measure of PWV is cfPWV.48 cfPWV considers the 
time of arrival of the forward pressure wave to proximal (carotid) and distal (femoral) sites 
relative to the R-wave of the cardiac cycle, which corresponds to ventricular contraction 
and blood ejection from the heart. The PWTT corresponds to the time in seconds it takes 
the pressure wave to propagate from the heart to the locations being measured, in this case, 
the common carotid (CCA) and femoral artery. The time of arrival is identified by the 
systolic upstroke of the pressure wave at the arterial site. PWTT is determined for both the 
proximal and distal sites from which the difference in time is calculated (distal-
proximal).48,55 Similar principles apply with calculating distance (metres) between sites 
(distal-proximal). While PWV is well accepted, several shortcomings exist which may 
confound the measure. Distance is most commonly estimated by measuring the surface 
distance on the body relative to the sternal notch using an inelastic tape measure.48 
Additionally, profound adiposity causes issues regarding ability to obtain certain 
waveforms accurately in addition to distance between measurement sites as body shape 
may influence the outcome measurement. No universally accepted distance measurement 
has been developed.48 
11 
 
 
 
 Central elastic arteries are most prone to stiffening; this relationship was identified 
as early as 1922 by Bramwell and Hill in their Nobel Prize winning study, which pioneered 
the measurement of PWV in humans.56 Normative values for cfPWV have since been 
established in a large European cohort study across 13 centres and in 11,092 participants.7 
Mean cfPWV varied from 6.2 m/s in young adults (≤30 years) to 10.9 m/s in older adults 
(≥70 years) with a proposed threshold of 12 m/s associated with significant clinical 
outcomes, although this study did exclude individuals with specific adverse cardiovascular 
conditions in order to achieve a relatively healthy sample (i.e. diabetes, dyslipidemia, and 
anti-hypertensive therapy).7 In fact, this large cross-sectional study determined that at any 
age the presence of elevated BP is associated with increased cfPWV. This relationship was 
identified with BP ranging from optimal (< 120/80 mmHg) to grade II/III hypertension (≥ 
160/100 mmHg).7 
Figure 2.1 Influence of blood pressure status on PWV across the lifespan. Increased cfPWV is 
observed at any age in individuals with progressively higher BP category. Taken from Boutouyrie.7 
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2.2.2 Peripheral Pulse Wave Velocity 
As previously mentioned, elastic central arteries are most prone to increased stiffening with 
increased age.49,56 This trend is not as significant in peripheral arteries due to the inherent 
arterial compositional differences in peripheral and central arteries. A Framingham 
Offspring cohort study investigated the effects of age on cfPWV and peripheral PWV 
(carotid-brachial and carotid-radial) in adults free of clinical cardiovascular disease.57 Age-
related increases in cfPWV but not peripheral PWV was identified in this study, although 
on average, up to age 50 years, peripheral stiffness was higher than cfPWV.57  
2.2.3 Local Arterial Stiffness 
Changes in arterial diameter occur as the forward pressure wave exerts an outward force 
against the arterial wall. Distensibility, or the relative change in vessel diameter for a given 
change in pressure, is a local measure of arterial stiffness and elastic properties.58 
Distensibility can then be computed as the difference between cross-sectional arterial 
diameter (ΔCSA= maximum – minimum CSA) divided by the product of PP and the 
minimal cross-sectional area:58 
𝐷𝑖𝑠𝑡 (𝑚𝑚𝐻𝑔−1) = 𝛥𝐶𝑆𝐴/(𝑃𝑃 ∗ 𝐶𝑆𝐴𝑚𝑖𝑛). 
 Distensibility is most commonly measured non-invasively using ultrasonography 
in the B-mode setting with a high-frequency linear array transducer.48 Measurement at the 
CCA is made 1-2 cm proximal to the carotid bifurcation. Calculation of distensibility 
requires applanation tonometry to non-invasively determine local PP at the level of the 
CCA or use of a transfer function which adjusts peripheral PP to the level of the CCA.  
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 The most dominant physiological processes known to affect arterial distensibility 
are aging and hypertension.6,59 In 1994, the first non-invasive study of the CCA pressure-
distensibility curve was conducted.6 From this study, it was found that at any given BP, 
CCA distensibility was not reduced in hypertensives compared with age and sex matched 
controls. In essence, the curves overlapped with the hypertensives having lower CCA 
distensibility at a higher BP. However, the compliance-diameter curve was shifted towards 
higher levels in the hypertensives, suggesting hypertension may be a result of both 
increased pressure and diameter. Thus, hypertension-induced changes in CCA structure 
plays a minimal role in the observed decreased distensibility and compliance.6 This 
population of hypertensives included never treated, chronic hypertensives, or those 
withdrawn from anti-hypertension medication for a period of 6 months prior to the study; 
this permitted the maximum likelihood of identifying structural changes and strengthens 
the principal findings of the study.6 In contrast, SBP, MAP, and PP have been found to be 
inversely related with CCA distensibility, with PP providing the strongest association in a 
population of normotensives and hypertensives.60 This association was identified across a 
wide range of BP values including those below clinical hypertension. Additionally, 
hypertension affects the functional properties of large centrally-located arteries more so 
than the smaller peripheral arteries.59 Generally, when hypertension is present, the effects 
on distensibility are more pronounced at any age.  
2.2.4 Intima-Media Thickness 
Arteries are composed of three distinct layers: intima, media, and adventitia.61 The intima 
is the innermost layer of cells which lies between the lumen and media layer of arteries.62 
The thickness of this layer, or intima-media thickness (IMT), changes with increasing age 
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and cardiovascular risk factor presence.63 Due to its accessible location via 
ultrasonography, researchers are able to measure IMT and investigate its clinical relevance 
in clinical and non-clinical populations (Figure 2.2). 
 
 
 IMT can be seen as a double line pattern on a vessel in a longitudinal view and can 
then be used for risk stratification and as end points in observational studies. The parallel 
boundaries are the lumen-intima and media-adventitia interfaces respectively.64 IMT is 
frequently measured at the CCA due to low likelihood of plaque formation in comparison 
to the internal carotid artery (ICA), a secondary site of IMT measurement. Anatomically 
speaking, the carotid bifurcation and ICA are more prone to plaque formation than the CCA 
which is more accessible to researchers.64 Therefore IMT measurement of the CCA is 
preferred over ICA.64 Increased IMT is associated with a number of cardiovascular and 
Figure 2.2 Ultrasound image of the CCA demonstrating arterial landmarks used for distensibility and 
intima-media thickness calculations. 
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cerebrovascular conditions including myocardial infarction, coronary artery disease, and 
stroke.65 As such, assessing IMT at the CCA is warranted when considering local arterial 
stiffness and systemic effects of stiffness on cardiovascular and cerebrovascular health. 
2.3 Autonomic Regulation of Heart Rate and Blood Pressure 
The autonomic nervous system is predominantly responsible for regulation of HR and BP 
through the sympathetic and vagal nervous systems which operate antagonistically, in most 
circumstances.66 Cardiac sympathetic stimulation via nerve fibres in the upper thoracic and 
lower cervical segments of the spinal cord decreases R-R interval (RRI) (time between 
consecutive R-waves of cardiac cycle). Increased vagal outflow via nerve fibres in the 
nucleus ambiguous of the medulla oblongata increases RRI.67 As such, RRI is dependent 
on the ratio of sympathetic to vagal stimulation.68 RRI and BP are influenced by the 
autonomic nervous system and are linked by several feedback mechanisms, namely the 
cardiovagal and sympathetic baroreflexes, chemoreflex, endogenous vasoconstrictor 
release and conservation of salt and water by the renal system.61 This thesis will focus on 
the cardiovagal baroreflex and its effects on beat-by-beat RRI and BP modulation. The 
arterial baroreflex is a negative feedback loop responsible for preventing large fluctuations 
in beat-by-beat BP.67 
2.3.1 Arterial Baroreflex 
Pressure sensitive baroreceptors embedded in the walls of the aortic arch and carotid sinus 
detect changes in arterial distension.69–71 Barosensory afferent nerves transmit this signal 
to neurons of the nucleus of the solitary tract (NTS) within the medulla oblongata via the 
glossopharyngeal (cranial nerve IX) and vagus nerve (cranial nerve X) which innervate the 
carotid sinus and aortic arch respectively.67 The arterial baroreflex is critical for 
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maintaining BP homeostasis to meet the body's demands. This task of beat-by-beat 
regulation is modulated by two different pathways, the sympathetic and cardiovagal 
baroreflexes (see Figure 2.3). Each pathway responds to the same stimulus of mechanical 
deformation of the arterial wall which is induced by changes in arterial pressure. 
Subsequent rapid adjustments in BP and RRI are due to mediation of the vagal and 
sympathetic components of the reflex arc which are under dynamic neural control.67,72  
 
 
 In the brainstem, the arterial baroreflex differentiates into two branches, the 
sympathetic and cardiovagal baroreflex. The sympathetic branch involves neural 
projections from the NTS to neurons of the caudal ventrolateral medulla (CVLM) which 
respond with inhibitory signals to neurons of the rostral ventrolateral medulla (RVLM).73 
Figure 2.3 Organization of the sympathetic and cardiovagal baroreflex pathways. Taken from 
Benarroch.67 
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These inhibitory signals are sent to the sympathetic ganglia via acetylcholine (ACh). The 
RVLM is a primary regulator of sympathetic activity.67,74 Therefore, when BP is elevated 
and the baroreceptors are activated, the NTS activates the CVLM, which in turn inhibits 
the RVLM. This results in a reduction of sympathetic activity leading to an increase in RRI 
(decrease in HR), decrease in cardiac contractility and vasodilation of peripheral arteries 
(i.e. decreased TPR) to reduce BP.67 The reciprocal is true for low BP which reduces the 
firing rate to the NTS, in turn increasing sympathetic outflow to consequently cause a rise 
in BP.  
The cardiovagal baroreflex originates within the NTS where the neurons of the NTS 
synapse with vagal preganglionic neurons of the nucleus ambiguous.67 Cholinergic neurons 
extend to the cardiac neurons (via vagus nerve branches) where they terminate in the 
sinoatrial and atrioventricular nodes of the heart. At these termination points, ACh is 
released, thus producing a negative chronotropic effect (decrease in HR).68 Therefore, 
when an increase in BP, or increased wall distension is detected by the arterial 
baroreceptors, the firing rate to the NTS is increased which results in decreased sympathetic 
outflow and augmented vagal outflow.67  
 The timing of this reflex loop differs depending on whether sympathetic or vagal 
stimulation is required as the difference in time delays between systems is substantial.75 
Vagal activation is almost immediate and requires 200-600 milliseconds (ms), whereas 
sympathetic activation requires a 2-3 second delay.68 Thus, beat-by-beat control of RRI is 
predominantly controlled by vagal activity. 
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2.3.2 Baroreflex Sensitivity 
Cardiovagal baroreflex sensitivity (cvBRS) quantifies the efficiency of the arterial 
baroreceptors' ability to regulate beat-by-beat RRI and BP. cvBRS is defined as the change 
in RRI ms per unit change in SBP (mmHg).72 Techniques of BRS assessment in humans 
have been extensively researched and include invasive and non-invasive methods. All 
methods require continuous electrocardiogram and arterial pressure recordings in order to 
regress concurrent changes in RRI against changes in BP. The slope of this relationship is 
an expression of the cvBRS and represents the increase in RRI (ms) per millimetre rise in 
mercury.68 When regressed against each other, the steeper the slope of the RRI-BP 
relationship, the greater the cvBRS value.68,76 Normative cvBRS values have been 
established and are known to range from 3-34 ms/mmHg depending on age, sex, and health 
status, although higher and lower values are possible.68,77 Reduced cvBRS (≤ 3 ms/mmHg) 
is associated with cardiovascular disease and death in patients following myocardial 
infarction.68 
2.3.2.1 Pharmacological Methods 
Early pharmacological methods designed to quantify cvBRS relied upon external 
perturbations that elicit changes in RRI and BP. One such method requires an intravenous 
injection of angiotensin II and saline to activate arterial baroreceptors.78 Rapid injection of 
angiotensin II elicits an abrupt rise in BP accompanied by cardiac slowing (increased RRI). 
Use of angiotensin II to induce this reflex was questioned as the cardiac response may not 
be of complete reflex origin (i.e. late tachycardia was likely a result of central sympathetic 
stimulation).76 The same research group then used a similar yet more selective pressor 
agent, phenylephrine, which does not induce direct effects on cardiac contractility and the 
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central nervous system.76 Infusion of phenylephrine is performed in a graded manner until 
SBP increases 20-30 mmHg, an indication of an optimal dosage.68 Since these early 
investigations, phenylephrine has been commonly used in laboratory based settings to 
assess cvBRS and is referred to as the Oxford method in respect to the institution from 
where the researchers originated. Further iterations of the Oxford method used bolus 
infusion of sodium nitroprusside and phenylephrine to induce a greater reflex response.79,80 
2.3.2.2 The Neck Chamber Method 
Neck chambers were first described by Ernsting and Parry in 1957 as a means to stimulate 
the carotid baroreceptors without the use of pharmacological interventions, which are 
known to not be entirely reflex in origin.76,81 This method requires a chamber which is 
placed around the individual's neck, resting between the upper thorax and neck. This 
chamber either produces positive or negative pressure pulses for 5-second, generally 
performed 2-4 times at pressures from -40mmHg to +80mmHg. Numerous chamber 
designs have emerged since the method was first introduced, although the underlying 
physiological mechanisms induced by each design remain unchanged.82 The carotid 
baroreceptors respond to increases in chamber pressure with a reflexive decrease in RRI; 
similarly, decreases in chamber pressure elicits reflexive increases in RRI.68,83 
 Neck chamber methods are advantageous for the assessment of cvBRS in that they 
allow for concurrent changes in RRI and BP by the carotid baroreceptors.68,82,83 
Additionally, neck chamber methods allow for baroreceptors to be assessed over a larger 
range of pressures in comparison to pharmacological methods. Furthermore, neck 
chambers permit the investigation of carotid baroreceptor activation under unique 
experimental conditions (i.e. exercise) which are otherwise not feasible with 
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pharmacological interventions. However, this methodology only permits the assessment of 
the carotid baroreceptors and neglects those of the aortic arch.67,70 Moreover, it is unknown 
precisely how much of the applied pressure is transmitted directly to the carotid 
baroreceptors, with studies reporting values ranging from 64-100% transmission.84,85 Thus, 
researchers have since pursued less intrusive methods of cvBRS assessment which require 
no additional equipment, and rely exclusively on basal variability in RRI and SBP. 
2.3.2.3 Spontaneous Methods 
Non-invasive, computer based methods of cvBRS assessment include sequence analysis 
(time domain) and spectral analysis (frequency domain). Time and frequency methods 
allow for observation of naturally occurring beat-by-beat BP and RRI fluctuations, thus 
enabling investigators to evaluate cvBRS without added devices or pharmacological agents 
in a time and cost effective manner. Importantly, due to the nature of the measurement 
itself, spontaneous methods allow for examination of the baroreflex as a closed-loop 
system.83 Furthermore, spontaneous analysis is well suited for detection of impaired cvBRS 
compared with traditional methods which often lead to conclusions of "normal" results.86 
In this sense, sequence and spectral analysis may be considered superior to 
pharmacological and mechanical manipulation methods at detecting early risk of morbidity 
and mortality in at-risk populations.83,87 
The sequence method uses the time domain while allowing for separate 
identification of "up" and "down" sequences of SBP and RRI. Sequence analysis allows 
for computer identification of sequences of three or more consecutive beats characterized 
by a progressive rise or fall in SBP and subsequent lengthening or shortening of RRI.87 
Typical accepted correlations of change in SBP and RRI are those of 0.85, which 
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demonstrates a high specificity. Most commonly, changes must be ≥1 mmHg and 5-6ms 
for SBP and RRI respectively to be included in regression analysis.87 The average slope 
between the regression line of the SBP and RRI changes can then be taken as an index of 
cvBRS.  
Spectral analysis, uses the modulus, or gain, of the transfer function between 
variations in SBP and RRI in the low frequency (LF) band (0.04-0.15 Hz) for quantification 
of cvBRS.88 The LF band is shown to be independent of the respiratory or high frequency 
(HF) band (0.15-0.4 Hz).89 Segments containing 128-1024 beats are required for analysis 
and are further quantified by discrete Fast Fourier Transform (FFT) of the SBP and RRI 
LF spectral powers.83 FFT incorporates all data in the spectral distribution and is commonly 
used on large samples due to its reproducibility and high processing speed.90 
 Specifically, transfer function analysis in the LF band is highly correlated to 
traditional phenylephrine and Oxford method derivatives.88 This method can be considered 
superior to phenylephrine for several reasons, chief among them being the non-invasive 
nature of the measure which relies on spontaneous oscillations in BP and RRI. Secondly, 
repetitive phenylephrine injection should be avoided due to potential modification of 
vascular smooth muscle tone in the walls of the CCA and aortic arch.83 A third advantage 
is that cvBRS values are not dependent upon the measurement method itself. One of the 
most important limitations to the Oxford technique is that significant associations are not 
always seen in individuals with autonomic impairment, whereas transfer function analysis 
is better suited for the detection of imbalances than pharmacological methods.88 For the 
aforementioned reasons, cvBRS will be assessed using spectral analysis in the LF band 
(0.04-0.15 Hz) for the present thesis. 
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2.4 Isometric Handgrip Exercise Training 
Isometric exercise involves sustained muscle contraction with no change in length of the 
working muscle group.91 Human models are unable to confirm pure isometric contractions, 
thus it is generally accepted that static contractions involve minimal change in muscle 
length. Isometric hand grip (IHG) exercise is widely used in clinical settings and involves 
a sustained low to moderate intensity contraction of the forearm musculature against a 
handheld device which provides feedback on contraction intensity. IHG exercise has 
gained attention due to the impressive hypotensive effects observed following a period of 
training and has now been recommended by the American Heart Association as a class IIB, 
evidence level C treatment strategy for BP management as an adjunct therapy for BP 
reduction.92,93 This classification was assigned to IHG training based on the limited 
populations investigated to date and having only received a consensus statement from 
experts in the field. The American Heart Association and Canadian Hypertension 
Education Program both recommend IHG training as a key lifestyle therapy for 
hypertensive individuals.92,93 
 Early on, researchers observed an association between isometric contractions in the 
workplace and low BP.94 This initial finding led to research into the potential mechanisms 
responsible for the hypotensive response to a hypertensive stimulus. When the acute effect 
of IHG exercise was formally investigated, it was determined that IHG induces modest 
increases in SBP and DBP (17 and 16 mmHg respectively) in accordance with increased 
HR and muscle sympathetic nerve activity (MSNA).95,96 Researchers have since developed 
formalized training regimens that have been proven effective at lowering resting BP in a 
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range of populations including young normotensive men and women, pre-hypertensive 
adults, and medicated hypertensive adults.17–19,96–98  
 Percentage of maximal voluntary contraction (MVC) is a simple prescription for 
training intensity of IHG contraction. Percent MVC requires individuals to perform a single 
maximal contraction of the involved limb producing a specific force output, which is then 
adjusted to a particular training intensity. Several studies have sought to elucidate the 
effects of training intensity on the hypotensive response to isometric training. An 8-week 
isometric bilateral leg training study in healthy males was performed in which one group 
exercised at 30% of subject specific maximal electromyographic output (similar to % 
MVC) and the second group exercised at 50%. There were no differences in ?̇?, stroke 
volume (SV) or TPR between groups following the 8-week training period demonstrating 
that 30% and 50% EMG produced similar training responses, however the 50% MVC 
group did achieve results at a faster rate than the 30% MVC group.17,95,97 As a result, 
subsequent studies have relied heavily upon 30% MVC as the desired training intensity.  
 Training frequency has also been a subject of investigation in determining optimal 
dosage to elicit BP reductions. In a study of young normotensive women using an identical 
IHG training program, groups trained 3 days per week (low frequency) or 5 days per week 
(high frequency), each for 8 weeks at 30% MVC.97 The high frequency training group 
experienced significant reductions in resting SBP at 4 weeks of training, whereas the low 
frequency group demonstrated significant SBP reductions at 8 weeks. Nevertheless, the 
study concluded that SBP reductions were equivalent to 6 mmHg in each group by the 8-
week mark.97 This suggests training at higher frequency (i.e. 5 days per week) results in a 
faster rate of adaptations than training at low frequency (i.e. 3 days per week), although no 
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difference is observed between groups by the 8-week mark. However, it is believed and 
recommended that using low-frequency training will result in higher retention rates and be 
an easier protocol for participants. Therefore, in line with 30% MVC contraction intensity, 
a frequency of 3 training days per week for a period of 8 weeks will be used. 
 Furthermore, BP reductions of greatest magnitude are typically observed in 
hypertensive populations, those with highest pre-training BP, and those with the greatest 
cardiovascular reactivity.95,98–100 Interestingly, medicated hypertensive patients do not 
consistently experience BP reductions seen in other populations.18,19,101 It has been 
postulated this may result from interacting effects of pharmacotherapy and the mechanisms 
by which BP reductions occur via chronic IHG exercise. Thus, IHG training is becoming 
an effective method of BP management in hypertensive individuals, although the 
mechanisms remain speculative. 
IHG training studies to date have emphasized measuring resting seated BP, similar 
to that which is assessed in clinical settings, however ambulatory BP monitoring over a 24 
hour period is considered the gold standard method for risk prediction associated with BP 
and is commonly used to assess Circadian patterns in individuals with suspected 
hypertension and white-coat hypertension.102,103 One study to date has assessed the 
influence of IHG training on ambulatory BP which demonstrated no change in BP 
following a training period of 8-10 weeks in a population of controlled (BP ≤120/80 
mmHg) hypertensive individuals.99 Thus, the robustness of IHG training on BP measured 
out of office (e.g. ambulatory BP) is currently unknown and requires future research.  
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2.4.1 Neural Control During Isometric Exercise 
Isometric contractions induce an exercise response which is controlled by two mechanisms: 
1) central command (CC) and 2) exercise pressor reflex (EPR).104 CC is a feedforward 
mechanism which sets basic patterns of motor activity (i.e. signals muscle contraction) and 
drives the cardiorespiratory activation patterns associated with exercise.104 CC activation 
results in vagal withdrawal and sympathoexcitation of HR.105 EPR is governed by the 
mechanoreflex (MR) and metaboreflex (MB). MR refers to the feedback control 
mechanism which is driven by intrinsic factors of the muscle itself.104 Mechanical 
compression of musculature results in blood flow occlusion and the subsequent 
accumulation of metabolites which activate the muscle MB.106 The MB is activated as 
metabolites accumulate due to insufficient blood flow from working muscles during 
contraction and thus, the MB increases vasoconstrictor sympathetic activity which acutely 
increases TPR and BP.106  
Acute bouts of dynamic and isometric exercise increase MAP, although isometric 
exercise does so in a progressive manner, resulting in considerably greater increases in 
MAP than dynamic exercise.105 A population of particular interest are hypertensive adults 
whom demonstrate an exaggerated response in MAP and MSNA to an acute bout of IHG 
exercise compared with normotensive adults.107  As such, it is hypothesized that the 
metabolic component of the EPR may be overactive in hypertensive adults compared to 
normotensive adults.107 In response to acute bouts of IHG, carotid baroreflex gain has gone 
unchanged following 35% MVC and during a period of post-exercise blood flow 
occlusion.108 However, these findings are limited to the carotid baroreceptors only as the 
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study utilized neck suction and pressure to elicit the changes in BP to measure carotid 
baroreflex function.  
2.4.2 Mechanisms of Action 
Thus far, researchers have only hypothesized around the physiological adaptations 
responsible for reduced arterial pressure observed with IHG training. Common theories 
involve increased bioavailability of nitric oxide (NO) and thereby reductions in arterial 
stiffness, reduced MSNA, and improvements in autonomic function.15,98,109,110 
2.4.2.1 Changes in Arterial Function and Stiffness 
Blood flow to working muscles is reduced and/or occluded during sustained isometric 
contraction and the degree of reduction is dependent upon contraction magnitude.91 
Importantly, when the contraction is released, shear stress of the forward pressure wave 
stimulates release of paracrine substances such as NO from the endothelium.111 Shear stress 
upregulates NO synthase to increase release of endothelium-derived NO, a potent 
vasodilator which can reduce short-term arterial stiffness and BP112; thus resulting in an 
acute hypotensive response. Repeated exposure to shear stress is thought to contribute 
towards improving basal NO bioavailability and bioactivity which may in turn be partially 
responsible for BP reductions observed following a period of IHG training.111 NO mediated 
endothelial reactivity to shear stress can be assessed by flow-mediated dilation (FMD) 
testing, which involves hyperemic response to local limb blood flow occlusion.113 FMD 
allows for evaluation of arterial diameter and is most commonly performed on the brachial 
artery. IHG training has been shown to improve vascular reactivity of the brachial artery 
in medicated hypertensives but not consistently in normotensives.109,114,115 Substantial 
improvements in endothelial dilation were noted in the trained limb of medicated 
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hypertensive individuals only, suggesting endothelial adaptations may be local as opposed 
to systemic.109 
 Under basal conditions, the NO synthase inhibitor NG-mono-methyl-L-arginine 
(LMNA) has been investigated in rats and humans.112,116 Following acute saline and 
LMNA infusion, pressure independent increases in cfPWV, equivalent to approximately 8 
years of aging, were detected in healthy men.112 Similarly, acute and chronic infusion of 
an NO inhibitor, NW-nitro-L-arginine methyl ester (L-NAME), in rats has been shown to 
increase aortic stiffness independent of changes in BP.116 Chronically, reduced NO 
bioavailability may lead to structural modification by which arterial stiffness is 
increased.116 Thus, an intervention thought to stimulate NO bioavailability (i.e. IHG 
training) may reduce central arterial stiffness in large arteries such as the aorta and its main 
branches in populations with already elevated central arterial stiffness such as hypertensive 
adults. The above findings support the idea that focus should shift towards effects of NO 
on large central arteries as opposed to smaller peripheral arteries and endothelial function 
in peripheral vessels such as the brachial artery, especially considering the dominant BP 
buffering effect of the large central arteries.117   
2.4.2.2 Changes in Autonomic Function  
Autonomic adaptations have also been suggested to occur with IHG training. Several 
studies have investigated autonomic adaptations following IHG training with mixed 
results.97–99,101 A possible synergistic effect of good BP control through pharmacotherapy 
and age may contribute to limitations in the ability to consistently identify improvements 
in autonomic function.99 
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Early research into the association of IHG training and autonomic function was 
performed in hypertensive men and women, most of whom were medicated.98 Significant 
reductions in SBP and MAP following IHG training were paralleled by a significant 
decrease in LF and increase in HF area of both HRV and BPV, along with non-significant 
decreases in both LF/HF ratios. These findings suggest that IHG training decreases 
sympathetic and increases vagal modulation of HR.98 In contrast, no adaptations were 
observed in HRV for a population of well controlled (~115/68 mmHg) hypertensive 
adults.99 In a similar population of well controlled medicated hypertensive adults, 8 weeks 
of IHG training induced a small BP reduction (~5 mmHg) and did not alter traditional time 
and frequency domain HRV data seen by Taylor et al..101 However, non-linear HRV 
analysis of heart rate complexity and predictability such as sample entropy, and fractal 
scaling distance scores were improved, which suggests improved cardiac vagal function 
following IHG training.118,119 Moreover, no changes in linear or non-linear HRV measures 
following IHG training were observed in healthy young adults, making the HRV 
adaptations in IHG training unclear.97 The variances observed in the above studies may be 
attributed towards level of BP control and effectiveness of the prescribed medications. 
Specific classes of BP medications target neural pathways involved in the HR reflex arm 
of the baroreflex and may have already exerted theoretical maximal effects on autonomic 
adaptations in HRV.5,99 
 Overall, the findings to date are equivocal and suggest that traditional measures of 
autonomic function (e.g. HRV) are not consistently improved with IHG training, although 
potential for improvement exists following training in populations with autonomic 
dysfunction, most notably hypertensive adults. However, the major limitation of relying on 
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HRV as a measure of autonomic function is the inherent variability in the measure itself. 
Possible secondary indices of autonomic function to investigate include BPV, MSNA, and 
BRS. No study to date has utilized IHG training to examine whether the cardiovagal 
baroreflex is altered following IHG training as it is the primary system responsible for 
short-term BP and RRI modulation (i.e. BRS).  
2.4.2.3 Changes in Muscle Sympathetic Nerve Activity 
Reduction in vascular sympathetic tone and/or MSNA may be associated with BP 
reductions attributed to IHG training.120 However, a study in healthy young adults was 
unable to identify an association between arterial pressure reductions and changes in 
MSNA (measured at the peroneal nerve) in response to 5 weeks of IHG training, suggesting 
that reduced arterial pressure does not necessarily require a concomitant reduction in 
MSNA.96 The lack of association may be related to young adults displaying lower BP and 
MSNA in comparison to hypertensive populations known to demonstrate higher levels of 
both variables. It is unknown in this study whether sympathetic activity to vascular beds in 
other regions was affected through the training and contributing towards the reduction in 
BP.96 Alternatively, the training stimulus may not have been sufficient in young adults to 
effectively lower BP and MSNA to the same extent as in hypertensive populations. 
2.5 Association Between Cognitive Function and Hypertension 
2.5.1 Global Cognition 
Studies investigating cardiovascular health and cognition have been severely limited by 
their selection of cognitive assessment, namely an overreliance on a single test of cognitive 
function, the Mini Mental Status Exam (MMSE).8 Studies have favoured the MMSE due 
to its ability to detect mild cognitive impairment (MCI) and dementia.121 Unfortunately, 
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the MMSE is better suited for the detection of MCI and dementia than as a strict indicator 
of global cognitive function.121,122 A test which is proposed to possess an improved ability 
to detect impairments in global cognition is the Montreal Cognitive Assessment 
(MoCA).122 The MoCA evaluates multiple cognitive domains including executive 
function, attention, orientation, language, verbal memory, and visuospatial memory to 
provide a more complete picture of global cognitive function than the MMSE.122 When 
compared with the MMSE, the MoCA has greater sensitivity in identifying MCI in 
community based older adults and is regarded for its widespread applicability to both 
healthy and at-risk populations.122 MoCA scores have been associated with age and 
education levels, but not sex in an ethnically diverse population based cohort.123 
2.5.2 Executive Function 
Executive function is an umbrella term describing the ability to manage cognitive processes 
such as working memory, task switching, planning and execution. Successful performance 
on tasks of executive function require a combination of attention and memory.124 Executive 
function and several subdomains are commonly tested for by an array of assessment tools, 
namely the Trail Making Test Parts A and B (TMT-A and TMT-B).  
The TMT-A provides information on baseline visual and motor speed while the 
TMT-B requires increased cognitive demand due to task switching.125 However, the 
increased trail length and perceptual variations between TMT-A and TMT-B have led 
researchers to question whether performance differences are due to executive function or 
simply a consequence of the task itself. Arbuthnott and Frank (2000) investigated several 
derivations of TMT-A and TMT-B scores in a healthy population and identified that 
executive function can be specifically determined using the ratio of TMT-B to TMT-A 
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(TMT-B/A).125 Many studies examining arterial stiffness and the TMT have neglected to 
use the TMT-B/A as a more direct assessment of executive function.126–128 
2.5.3 Verbal Fluency 
Verbal ability and verbal fluency are differentially affected by aging and clinical conditions 
comparatively. Verbal ability appears to be a crystallized skill which is unaffected by age 
whereas verbal fluency requires significantly greater executive ability to initiate and 
maintain effort to a directed task.129 Verbal fluency tests assess verbal ability via two 
aspects 1) lexical access ability, which refers to the ability to retrieve grammatical 
representations of sound from the mental lexicon and 2) executive control ability, or the 
ability to regulate thoughts and direct attention towards a specific goal upon request.130 In 
order to be successful, individuals must possess the ability to retrieve appropriate words 
from their mental lexicon, in addition to avoidance of word repetition.131  
In clinical practice, several studies have utilized verbal fluency tests in hypertensive 
populations and examined the association with distinct cardiovascular variables. Poels et 
al. assessed category fluency in healthy older adults and found cfPWV was associated with 
performance on this test.132 In contrast, Zhong et al. assessed letter fluency and were unable 
to find an association with cfPWV in a predominantly hypertensive population.127 A recent 
study conducted by Spinelli et al. investigated the relationship between several cognitive 
assessment scores, including verbal fluency tests, and hypertension.133 The study 
concluded that hypertensive individuals with poor ambulatory blood pressure (ABP) 
control displayed reduced letter fluency scores than those with good ABP control.133 
Interestingly, separate cortical regions appear to be recruited in category and letter fluency 
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tests which may explain a portion of the variance in results such as those of Poels and 
Zhong.127,132,134,135  
2.5.4 Depression 
Depression is a potential confounder which has been largely excluded in studies 
investigating cognitive function and hypertension.8 The Center for Epidemiological 
Studies Depression Scale (CES-D) is a widely used tool to assess depression and depressive 
symptoms in multiple ethnicities and demographics.136 The CES-D measures current 
depressive symptoms with an emphasis on depressive mood and is beneficial when 
examining short-term changes in depressive symptoms and during intervention studies.137 
The CES-D consists of 20 questions which are answered on a 4 point Likert scale based on 
frequency of symptom occurrence with cumulative scores ranging from 0-60 and scores ≥ 
16 indicating possible clinical depression.  
Recent clinical findings suggest that depressive symptoms affect responses on self-
report questionnaires and are correlated with objective measures of retrospective and 
prospective memory.8,136 Thus, when using self-report questionnaires and subject based 
assessments of cognition, it is wise to screen for presence of depression.  
2.6 Pathophysiology of Hypertension Induced Cognitive Dysfunction 
There are two prevailing theories on the mechanisms underlying reduced cognitive 
function in hypertensive individuals; 1) hypertension may exert direct effects on the brain, 
or 2) systemic arterial stiffening may affect brain white matter and microvasculature.12 
Current evidence favours the latter. In addition to increased central arterial stiffness (i.e. 
cfPWV), hypertension induces increased cerebral vascular wall stiffness and thickness, 
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resulting in hypoperfusion and cerebral vasoconstriction.10,138,139 Hypoperfusion in 
hypertensive adults may be a contributing factor towards cognitive deficits resulting from 
impaired neurotransmission.140 In fact, dissociations in blood flow to cortical regions often 
result in lesions to regions of high white and grey matter density such as the corpus 
callosum.10 Furthermore, sustained high BP is associated with loss of arterioles and 
capillaries (rarefaction) in the brain.10 
 The above pathological adaptations in the brain occur more commonly and to a 
more severe extent in hypertensive individuals than normotensives.10,13,141 These 
adaptations generally include increased presence of white matter hyperintensities (WMH), 
reduced grey matter, and brain atrophy.10,142 In hypertension, these changes indicate 
accelerated brain aging and neurodegeneration which can be attributed to the complex 
interplay between vascular damage and functional reorganization of the brain.10,143 Without 
the use of magnetic resonance imaging (MRI), the contribution of WMH and related 
structural damage to cognitive decline are unclear, and the effects of IHG training on 
progression or attenuation of WMH are unknown. However, it is important to acknowledge 
the probability of WMH and structural damage which may contribute towards cognitive 
impairment in a hypertensive population.  
A critical region of information integration is the NTS.144 Ascending from the NTS 
is the vagus nerve which reaches to the thalamus, paraventricular nucleus, amygdala, 
hippocampus, anterior cingulate cortex (ACC), and prefrontal cortex (PFC).144 
Dysfunction in the NTS may contribute towards upstream disturbances in cognitive 
processes.144 Specifically, the frontal lobe, ACC, hippocampus, and parietal cortex are 
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affected by hypertension.144–146 Disruptions in neural pathways and increased arterial 
stiffness may each play a role in attenuated cognition observed in hypertensive populations. 
2.6.1 Blood Pressure and Cognition 
Cross-sectional evidence indicates a negative linear association between SBP and 
cognition (Figure 2.4).14 In community dwelling adults (mean age = 64 years), global 
cognitive performance and SBP were inversely related along the SBP spectrum.14 
Observing this association at the low end of the SBP spectrum suggests a minimal BP is 
required to maintain sufficient perfusion pressure to the brain and subsequently maintain 
cognitive function.16 Importantly, this study used an array of cognitive assessments that 
tested multiple domains including memory, attention and executive function.14 Brady et al. 
identified similar associations in men (mean age = 67 years) of varying BP categories and 
found uncontrolled hypertension produces cognitive deficits specific to category fluency 
and immediate recall beyond which can be attributed to the influence of age alone.147 
 
 
Figure 2.4 Association of global cognitive function across a range of SBP values. Taken 
from Knecht 2008.14 
35 
 
 Research consistently implies an association between hypertension and cognitive 
impairment, although the association exists along the BP spectrum.14,148 Many studies 
investigating BP and cognition are limited by their selection of cognitive assessments, 
namely an overreliance on a single test of cognitive function.8 Use of cognitive test 
batteries assessing multiple cognitive domains is becoming more widely used in research. 
Hypertensive adults have been shown to experience impairments in executive function, 
episodic and working memory, and speed of cognition.149 Similarly, a more recent study 
identified hypertension-related impairments in attention, memory, and executive 
function.150 Elderly hypertensives demonstrated impaired working memory and delayed 
recall (long-term memory) in comparison with normotensives. In addition, close to 50% of 
the hypertensive adults in this sample were unable to complete the TMTB and performed 
a higher number of mistakes on the test than normotensives.150 The authors concluded that 
effective BP management has the potential to reverse or attenuate losses in cognition 
associated with hypertension.   
 As such, studies designed to optimize hemodynamic stress and attenuate the rate of 
cognitive decline through effective BP management strategies among high-risk groups are 
needed.16 The increasingly well-defined relation between SBP and various domains of 
cognition lends itself to identifying potential improvements in cognitive function following 
an intervention which specifically targets BP reduction. Whether IHG training is able to 
decrease SBP and improve cognition in hypertensive adults will be investigated in the 
present study.  
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2.6.2 Regional Arterial Stiffness and Cognition 
Hypertension is considered a model of accelerated vascular aging which has been 
consistently associated with reduced cognitive function.7,126,151,152 For example, in newly 
diagnosed, never treated hypertensive adults, an association between cfPWV and cognitive 
impairment was identified.153 An independent association between cognitive function and 
microvascular damage was not observed in this sample suggesting a temporal association 
between duration of exposure to high BP and microvascular damage. In contrast, a positive 
association between cfPWV, extent of WMH damage and silent cerebral infarcts was 
present independent of age, MAP and vascular risk factors in hypertensive adults free of 
cardiovascular and cerebrovascular disease.154 However, this study did not investigate 
severity of WMH with concurrent assessments of cognition. The continuous relationship 
between cfPWV and WMH suggests an absence of clear-cut thresholds. One large 
population-based study suggested PWV ≥12 m/s is associated with reduced cognition.127 
In a separate study, each standard deviation (SD) increase in cfPWV was associated with 
poorer cognitive function.155 This association was found for global cognitive function, 
psychomotor speed, and perceptual speed.155 
 Extreme examples of the association between arterial stiffness and cognition are 
seen in populations recruited specifically for reported memory complaints and/or memory 
loss. Hanon et al. investigated 4 such groups based on severity of cognitive impairment: 
normal cognition, MCI, Alzheimer's disease, and vascular dementia.152 Severity was 
significantly correlated to cfPWV (i.e. normal cognition demonstrating lowest cfPWV, 
vascular dementia had highest cfPWV). A reported 76% of the sample was hypertensive, 
while 70% of these individuals were medicated for hypertension.152 
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 Longitudinal studies have primarily been interested in baseline arterial stiffness and 
changes in cognition. Similar to cross-sectional studies, the majority of longitudinal 
research to date supports the association of increased cfPWV with accelerated rates of 
cognitive decline in adults.11,155,156 One of the first longitudinal studies to investigate 
arterial stiffness and cognition was performed in older adults with complaints of memory 
loss.157 This investigation revealed cfPWV was a significant predictor of loss in cognition 
independent of age, sex, education and cardiovascular risk factors at an average follow-up 
of 12 months.157 One longitudinal study failed to find an association between cfPWV and 
cognitive decline in a population based sample of adults aged 55 years and older.132 
Although cross-sectional analysis of this sample did identify small associations with 
stiffness and cognition, most specifically executive function.132 The majority of large 
population based studies conclude that the greatest cognitive declines are often observed 
in individuals with highest baseline stiffness.11,132,158 
 Thus, cross-sectional and longitudinal research supports associations between 
increased cfPWV and reduced performance on common assessments of cognitive function. 
Considering hypertension is widely regarded for accelerating the progression of cfPWV, it 
is anticipated that the association of cfPWV with cognitive function will likewise be 
accelerated in hypertensive individuals. Lowering BP through IHG exercise training may 
provide one method by which the cfPWV and cognitive function association can be 
attenuated or even improved.  
2.6.3 Common Carotid Artery Distensibility and Cognition 
Measuring CCA distensibility in hypertensives is warranted when investigating changes in 
cognitive function as it may provide further information on pathways which contribute 
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towards functional impairment and structural adaptations. Less distensible arteries in 
hypertensives are associated with cerebral hypoperfusion and reduced oxygen delivery to 
the brain.159 Hypoperfusion in elderly adults whom underwent aggressive BP reduction, 
has been shown to result in syncope, falls and declines in cognitive function.160 Successful, 
long-term anti-hypertensive treatment has been shown to improve CCA distensibility, 
which correlated with concomitant changes in cerebral blood flow.139,161 Therefore, 
improvements in CCA distensibility from a BP lowering intervention (primarily ACE 
inhibitors) appear to be mirrored by similar improvements in cerebral perfusion. Taken 
together, assessment of CCA distensibility should be sufficient to comment on changes in 
perfusion short of directly measuring blood flow velocity following BP reduction. 
 Few studies have explored CCA distensibility and cognition. One study comparing 
sedentary and endurance-trained older adults found that when CCA distensibility was 
controlled for, between-group differences in cognition were abolished.126 In contrast, CCA 
distensibility was not predictive of cognitive decline or dementia within the Rotterdam 
study, a prospective population-based cohort study of adults older than 55 years.132 
However, those who attended the follow-up sessions were younger and of better 
cardiovascular health than those whom did not follow up, thus selective attrition bias may 
have confounded the results. Thus, changes in CCA distensibility may result in 
improvements in blood flow and regulation of the forward pressure wave into the brain 
microvasculature, with the potential for modest functional improvements in cognitive 
performance.  
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2.6.4 Autonomic Function and Cognition 
Research into autonomic function and cognition is largely unexplored, however the neural 
pathways common to autonomic regulation of HR and BP, and cognition, stem from the 
NTS.144 Dysfunctions in the NTS may compromise efferent activity to the vagus nerve and 
promote pathological higher order CNS activity, thus resulting in compromised 
neurocognitive activity.144 Furthermore, lesions to the NTS have been shown to attenuate 
central baroreceptor pathways.162 Evidence is emerging that this relationship may in fact 
be bidirectional, such that autonomic dysfunction progresses to cognitive impairment via 
systemic hypotension, or neurodegenerative processes influence autonomic pathways and 
thus resulting in autonomic dysfunction.163–165 As such, the relationship between 
autonomic function (i.e. HRV and cvBRS) and cognitive functioning is complex and 
warrants further investigation. 
 Regarding indices of autonomic function, researchers have focused on HRV and 
cvBRS as a means to explore associations between detriments in cognition and autonomic 
function. The Irish Longitudinal Study was the first to observe attenuated HRV in 
individuals with low scores on the MoCA, a representative test of global cognition which 
tests six specific domains.165 Researchers identified low scores in two domains; verbal 
recall, and language.165 Importantly, this study was the first to identify an association 
between HRV and global cognition at a population level, although others have reported 
associations between HRV and verbal recall.165,166 One study which evaluated the 
predictive ability of cvBRS on cognitive function in a healthy elderly sample of community 
dwelling adults, found cvBRS to be positively associated with attention and memory.145 
Furthermore, using both compound and z-scores, cvBRS was a predictor of memory z-
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score. In particular, individuals with cvBRS 3-6 ms/mmHg displayed a 1.82 greater risk of 
developing cognitive impairment in the memory domain.145 These findings reinforce those 
of the Irish Longitudinal Study listed above, which identified lower HRV quintiles were 
associated with lower MoCA scores.165 
 The hypothesis that neural pathways between the brainstem region and cortical 
areas are involved in cognitive processes needs to be further explored.145 As indicated 
above, pathways involved in autonomic regulation of RRI and BP may be affected by 
disrupted signalling in the NTS, also resulting in reductions in cognitive functioning.144 
Whether an intervention which targets BP reduction can improve both autonomic and 
cognitive function has yet to be investigated. As higher cvBRS is generally observed in 
healthy populations, it is speculated that BP reduction can improve cvBRS and result in 
secondary improvements in cognition, especially within the memory domain.145 
2.7 Intervention Studies 
Exercise is associated with attenuated loss of cognition and enhanced brain health in a 
variety of populations.167 Aerobic exercise in particular has been shown to improve neural 
and non-neural regulation of BP and result in beneficial effects on brain structure and 
cognitive function.168 In agreement, aerobic exercise training results in improvements in 
cognitive function by both BP dependent and independent pathways.167 Although the 
benefits of aerobic training on cardiovascular and cognitive health are clear, the effects of 
different exercise modalities on cognition are less well understood.  
 Chronic aerobic exercise is shown to result in lower central arterial stiffness, 
increased regional cerebral perfusion, and higher cognitive function when compared with 
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sedentary age-matched controls.126 Collectively, these changes in cardiovascular health 
induced by aerobic exercise result in improvements in cerebrovascular /cognitive health 
which in turn may result in the greater cognitive function often observed in aerobically 
trained individuals. As such, the majority of evidence to date suggests that chronic aerobic 
exercise positively influences cognitive health.  
When aerobic exercise is used over a 4-month period in addition to a combination 
of caloric restriction and dietary approaches to stop hypertension, improvements in 
neurocognitive function have also been observed.169 Change in SBP was a significant 
moderator of the effects of diet and exercise on neurocognitive function in 
overweight/obese individuals.169 Although the participants in this study were classified as 
pre-hypertensive or hypertensive, none of the participants were medicated, thus limiting 
the applicability of these findings to the general hypertensive population. Furthermore, this 
study employed a drastic lifestyle change which may not be easily integrated into everyday 
life. Thus, there may be a need for an intervention which can be easily adapted into daily 
life, have a high compliance rate, and similar effects on cognitive function. 
 In conclusion, several studies have been able to successfully identify improvements 
in cognitive function and related factors such as cerebral blood flow following an 
intervention which results in reduced BP. This has been shown in studies which employed 
dietary, pharmacological and exercise based interventions.161,168,169 Regarding exercise 
studies and cognitive health, there is considerable need to examine how modalities other 
than aerobic exercise can influence cognitive health, specifically in a hypertensive 
population. A recent review on exercise, brain health, and hypertension concluded that 
studies utilizing exercise modalities other than aerobic training need to be investigated to 
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develop a more complete understanding of the relationship between hypertension and 
cognition; specifically citing IHG exercise as one such exercise modality.167 This is in 
alignment with the purpose of the present thesis. 
2.8 Objectives 
This study aimed to investigate several objectives surrounding cardiovascular and 
cognitive health in hypertensive adults:  
1. To determine the effects of 8-weeks of IHG training on markers of arterial stiffness 
and function (i.e. CCA distensibility, ctPWV, crPWV), in comparison to a non-
exercising control (CON) group.  
2. To determine the effects of 8-weeks of IHG training on autonomic function (e.g. 
cvBRS, HRV) in comparison to CON. 
3. To examine adaptations in cognitive function following 8-weeks of IHG training in 
comparison to CON group. 
2.9 Hypotheses 
It was hypothesized that: 
1. IHG training would improve local arterial stiffness and structure in the CCA. 
Specifically, IHG training would decrease resting BP, and the changes in systemic 
(i.e. ctPWV) and upper-limb (crPWV) arterial stiffness would be significantly 
different between IHG and control (CON) groups over the 8-week intervention, 
indicating that IHG training would reduce regional arterial stiffness. Additionally, 
that the changes in CCA distensibility and diameters would be significantly 
different between study groups over the 8-week intervention. 
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2. IHG training would result in a significant change in cvBRS in the IHG group 
compared with the CON group. Furthermore, HRV change would be significant in 
the IHG but not CON group. 
3. IHG training would result in significant improvement in measure of cognitive 
function in the IHG group compared with the CON group. 
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3 Chapter 3 - Methodology 
3.1 Study Design and Sample 
This study received approval from the Brock University Biosciences Research Ethics 
Board (BREB, #15-065), and was conducted on adults in the Niagara region whom were 
medicated for hypertension. A repeated measures study design was utilized which involved 
a training group (IHG) and a control group (CON). Due to time considerations, the first 
eight individuals were allocated into the IHG group and the remaining individuals who 
contacted researchers regarding the study were placed into the CON group. 
 
 
3.2 Recruitment Protocol 
Hypertensive adults were recruited from the Niagara region through a poster and email 
campaign and the cooperation of several local physicians. Individuals who expressed 
Figure 3.1 Overview of sample sizes by arterial mechanical properties and cognitive data. 
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interest in participation contacted the researchers to schedule an initial BP assessment and 
explanation of the study requirements.  
 Initial eligibility criterion required the participant to be medicated for hypertension, 
while the exclusion criteria consisted of hospitalization within the last three months, 
undergoing a medication change within the last two months, and a physical limitation 
which prevented proper performance of the IHG exercise. Visit 1 consisted of a complete 
explanation of the procedures which participants were expected to follow as part of the 
IHG or CON group in addition with expectations of laboratory based procedures as 
outlined in the Information Letter (Appendix A). If individuals were still interested in 
participating, they were asked to read and sign the Informed Consent form (Appendix B). 
A brief Medical, Physical Activity and Educational History questionnaire was then 
administered to each participant (Appendix C). Education was scored on a 4-point scale 
consisting of secondary-school education, college/2-year degree, bachelor’s degree, or 
graduate degree. Additionally, all women responded to a question on menopause status and 
whether they currently or have ever used hormone replacement therapy. Following this, 
resting BP and HR were measured and recorded using an automated brachial oscillometric 
device (Omron Healthcare, HEM-780CANN, Illinois, USA). Seated resting BP and HR 
were measured four times, separated by two-minutes, and the final three measurements 
were averaged.115 A second visit was then scheduled. 
 Visit 2 consisted of resting BP and HR measurement identical to that conducted at 
Visit 1. The average resting BP of Visits 1 and 2 was then calculated. The study investigator 
then conducted the MoCA, COWAT, TMT-A and TMT-B testing protocols. Participants 
then completed a familiarization session for the IHG exercise protocol to habituate them to 
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the exercise protocol. Following the above procedures, participants were provided with a 
copy of a physical activity readiness questionnaire (PARmed-X) and Health Care Provider 
(HCP) form which were to be returned and signed by their regular physician before their 
first testing session. The signed HCP form was the final step in the recruitment process, 
signifying physician approval and acknowledgement of their participation in the study. If 
all of the above requirements were met, subjects scheduled their first laboratory testing 
session with the researchers.  
3.3 Outline of Experimental Measurements 
Following the above protocols for study eligibility and HCP approval, participants reported 
to the Human Hemodynamics Laboratory (Welch Hall, room 22) where non-invasive 
assessments of cardiovascular health took place. Each participant was instructed to follow 
their standard medication regiment on all laboratory testing days and for the full study 
duration. Participants were instructed to avoid strenuous physical activity for the 24 hours 
prior to the start of testing, refrain from eating for four hours leading up to the start of 
testing, and to not drink caffeine or exercise on the day of testing.30 
 On the day of laboratory testing, participants were asked to void their bladder before 
being outfitted with laboratory equipment as a distended bladder has been shown to 
increase BP.170 Anthropometric data was collected as standing height (m) and body mass 
(kg). Participants rested supine on a bed in a dimly lit room and were outfitted with a 
standard single-lead electrocardiogram for beat-by-beat collection of RRI. Additionally, a 
finger cuff was placed on the left middle phalange to collect beat-by-beat BP as well as a 
pulse oximeter on the left second toe. During this time, three manual BP readings were 
taken via the auscultation method by the researchers on the right upper arm. Beat-by-beat 
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data collection of RRI and BP was continuous throughout the laboratory session. Following 
a period of 10-minutes of continuous RRI and BP data collection, carotid ultrasonography 
was performed on the right CCA for a series of three five beat cycles.171 Local PP was 
taken on the right CCA using applanation tonometry for a minimum of 15 beats.  All of the 
experimental measures and cognitive assessments were conducted pre and post 8-weeks of 
IHG training and analyzed by the same researcher to minimize inter-observer variability 
within and between participants. 
3.3.1 Cognitive Assessments 
3.3.1.1 Montreal Cognitive Assessment  
The MoCA  (Appendix D) evaluates several cognitive domains such as executive function, 
attention, concentration, orientation, visuoconstructional skills, conceptual thinking, 
language, and verbal and visuospatial memory.122 The suggested normal range of scores 
falls between 27-30 points on a 30 point scale; scores ≤26 are indicative of MCI.122 
Importantly, the MoCA has been demonstrated to be a more sensitive tool than the MMSE 
for the detection of MCI in less severe cases.122,172 The MoCA was used in the present 
study to identify MCI and classify global cognition at baseline only. 
3.3.1.2 Trail Making Test Parts A and B 
The TMT-A (Appendix E) and TMT-B (Appendix F) are commonly used to assess multiple 
cognitive domains including visual search, scanning, speed of processing, mental 
flexibility and executive function.173 TMT-A involves drawing a line which connects 
consecutive numbers from 1-25 whereas TMT-B involves drawing a similar line which 
alternates connecting numbers (1-13) and letters (A-L) in ascending order. Alternate 
versions of the tests have been developed in order to help control for early rapid 
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improvements observed in test-retest scenarios.174,175 The present study utilized these 
alternate test versions for pre and post-training for all participants. The difference in time 
between TMT-B and TMT-A (TMT-BA) and ratio of TMT-B to TMT-A (TMT-B/A) were 
used in addition to individual test scores; the TMT-B/A was used as an index of executive 
function, as suggested by Arbuthnott and Frank.125  
3.3.1.3 Controlled Oral Word Association Task 
The COWAT is a letter fluency test which requires individuals to produce as many novel 
words beginning with the same letter as possible within three 60 second trials. Accepted 
forms of the COWAT include three possible letter combinations: FAS, CFL, and PRW.176 
However, the FAS version is believed to be of lower difficulty compared to the CFL and 
PRW versions, thus making it unsuitable for pre- post- comparisons.177 Standard clinical 
practice for use of the COWAT utilizes the CFL in initial testing with PRW used in follow-
up tests.129 The present study was conducted according to these standards with the CFL 
trial being conducted at pre-training and PRW trial being conducted at post-training.  
3.3.1.4 Center for Epidemiological Studies Depression Scale 
The CES-D (Appendix G) measures current depressive symptoms with an emphasis on 
depressive mood and is beneficial when examining short-term changes in depressive 
symptoms such as intervention studies.137 The CES-D is used to assess depression and 
depressive symptoms in multiple ethnicities and demographics.136 The CES-D contains 20 
questions which are answered on a four point Likert scale based on frequency of symptom 
occurrence within the past week. Cumulative scores range from 0-60 with scores ≥16 
indicating presence of depression.137  
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3.3.2 Anthropometry 
Participants were assessed without shoes while wearing light clothing. Height (m) was 
measured using a wall mounted stadiometer (STAT 7X, Ellard Instrumentation Ltd., 
Monroe, WA, USA) and body mass (kg) using a calibrated electronic medical scale (BWB-
800S, Tanita Digital Scale, Tokyo, Japan). Body mass index (BMI) was calculated by 
dividing body mass by height squared (kg/m2). Waist circumference (cm) was taken around 
the narrowest point and hip circumference (cm) at the greatest gluteal protuberance.178 
Each of the circumference measures were taken in duplicate to ensure accuracy.  
3.3.3 Cardiovascular Measurements 
3.3.3.1 Blood Pressure and Heart Rate 
Resting seated BP and HR were measured and recorded using an automated brachial 
oscillometric device (Omron Healthcare, HEM-780CANN, Illinois, USA). Seated resting 
BP and HR were measured four times, separated by two-minutes, and the final three 
measurements were averaged.115  
Resting supine beat-by-beat BP and RRI was noninvasively assessed throughout all 
laboratory based testing. Beat-by-beat BP was measured using a photoplethysmograph cuff 
(Nexfin, BMEYE,Amsterdam, Netherlands) attached to the left middle finger to collect 
measures of SBP and DBP. RRI was recorded using a standard single lead 
electrocardiogram. Both BP and RRI were sampled at 1000 Hz, thus providing a basic 
resolution of 1 ms, which is considered an optimal digitization rate.179 
 As well, three manual BP readings were taken on the right arm using a standard 
mercury sphygmomanometer while resting in the supine position, as is standard practice in 
50 
 
the Human Hemodynamics Laboratory.180 Averages of the last two BP measures 
represented a resting supine brachial artery BP. The BP average was used to adjust the 
beat-by-beat BP values obtained at the finger using the Nexfin.  
3.3.3.2 Common Carotid Artery Distensibility and Intima-Media Thickness 
Following beat-by-beat data collection, resting arterial diameters were measured at the 
CCA. A minimum of three non-invasive imaging sequences consisting of five beat-by-beat 
diameter changes in the right CCA were recorded using Echo-Doppler ultrasound (Vivid 
q, General Electric Medical Systems, Netherlands) from a location approximately 1-2 cm 
proximal to the carotid bulb. CCA pulse pressures were taken non-invasively using 
applanation tonometry (Millar Instruments, Texas, USA) and a consistent 15 beat average 
was taken.171 Ultrasound images were stored in Digital Imaging and Communications in 
Medicine (DICOM) format for offline analysis. Two of the best quality images were used 
for determining diameter measurements in systole and diastole. End-diastolic frames were 
determined at the time of the R-spike of the ECG recording and end-systolic frames were 
determined at the time of the T-wave of the ECG recording. Three cardiac cycles for each 
of the two images were chosen; therefore six total images were examined. These images 
were stacked in a new DICOM file using commercially available software (Sante DICOM 
Editor, V. 3.1.24; Santesoft, Athens, Greece). Images were then analyzed using a semi-
automated edge-tracking software (Artery Measurement System II, Image and Data 
Analysis; Gothenberg, Sweden) in a specified region of interest. IMT was measured at end-
diastole at the far wall for the same cardiac cycles as the vessel diameters. Pulsatile cross 
sectional area (CSA; m2, where r = radius), and the corresponding CCA pulsatile pressure 
were used to determine vessel distensibility using the standard equation: 
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𝐷𝑖𝑠𝑡 (𝑚𝑚𝐻𝑔−1) = ∆𝐶𝑆𝐴/(𝑃𝑃 ∗ 𝐶𝑆𝐴𝑚𝑖𝑛) 
3.3.3.3 Pulse Wave Velocity 
Pressure waveforms were recorded for a minimum of 15 cardiac cycles at the left CCA, 
radial and femoral arteries.171,181 Pulse wave contours were taken using a hand-held 
applanation tonometer (Millar Instruments, Texas, USA) which incorporates a high-fidelity 
strain gauge micro-manometer on the flattened end of a pencil-type probe. This probe was 
positioned against the artery (i.e. CCA, radial and femoral arteries) to permit accurate 
registration of arterial pressure waves. Ideal conditions for applanation tonometry involve 
a flattening of the wall of an artery by the sensor which eliminates tangential pressures.182 
A pulse oximeter (Nellcor N-200 Tyco Healthcare Group LP, Pleasanton, CA, USA) was 
placed on the left second toe to similarly acquire a pulse wave contour. 
The foot of each pressure waveform was identified using a bandpass filter (5-30 
Hz) as has been previously used in assessments of PWV.183 PWTT was then calculated 
relative to the R-wave of the ECG signal. The direct distances from the sternal notch to the 
carotid artery,  femoral artery, and radial artery were measured using an inelastic tape held 
over the body. The difference between distal arterial distance (Dd) and proximal arterial 
distance (Dp) were then divided by the difference in PWTT of the distal (Td) and proximal 
(Tp) waveforms. PWV was then calculated using the subtraction method as:58 
𝑃𝑊𝑉 = (𝐷𝑑 − 𝐷𝑝)/(𝑇𝑑 − 𝑇𝑝). 
3.4 Isometric Handgrip Exercise Training Protocol 
Participants took part in an 8-week IHG training protocol. The protocol consisted of 
training three times a week. At each session the participants would perform two maximal 
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contractions (one per hand) at the beginning. From these contractions each participants 
30% MVC was determined. Each participant then completed four sets of two minute 30% 
MVC IHG contractions separated by a one-minute rest period (Figure 3.2). Participants 
alternated the limb performing contractions. Two of the three weekly training sessions were 
monitored by the researchers at the Human Hemodynamics Laboratory at Brock University 
or the Brock-Niagara Centre for Health and Well-Being; the third session was unsupervised 
after participants were provided with a detailed description of how to properly conduct the 
session alone. No adverse events were reported in response to the IHG training in our 
sample and participants demonstrated 100% adherence to the IHG training program. 
 
 
3.5 Data Analysis 
Calculations of BMI, WHR, CCA distensibility and diameters, and crPWV and ctPWV 
were made following data collection according to standardized equations (see above). 
Average RRI was calculated using the average time (ms) from R-wave to R-wave within a 
stable 1-minute period during the data collection. 
Figure 3.2 Isometric handgrip exercise training protocol. 
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3.5.1 Cardiovagal Baroreflex Sensitivity and Heart Rate Variability  
Beat-by-beat RRI and BP data was collected at 1000 Hz on Powerlab and Chart 7 PRO, 
ADInstruments and transferred into excel (Microsoft, 2010). The cleanest, most stable 5-
minutes of data was used for BcvRS analysis. The R-R sequences were visually inspected, 
and if any data was considered artifactual, it was manually replaced with interpolated data 
to ensure linear extrapolation in the time domain. Using Matlab (MathWorks 2013b), 
suitable series of RRI and SBP were subjected to FFT analysis for HRV (LF:0.04-0.15 Hz 
and HF:0.15-0.5 Hz), and transfer function analysis in of the LF domain for the calculation 
of cvBRS.75,184  cvBRS gain relationships were only accepted when the coherence was  
≥0.5.185,186 
3.6 Statistical Analysis 
Descriptive analysis are presented as mean ± SD for physical (sex, age, height, body mass, 
BMI, and waist and hip circumference), cardiovascular, and cognitive variables. The 
Shapiro-Wilk test of normality was used to determine whether data were normally 
distributed. Baseline between group differences were assessed by Fisher’s exact test for 
categorical variables and independent samples t-tests for continuous variables. For training 
effects, pre- and post IHG training difference scores were calculated for IHG and CON 
groups for all variables and compared using independent samples t-tests. All statistical 
analyses and sample size calculations were performed using SAS (v9.4, SAS Institute, 
Cary, NC). Graphs were created using SigmaPlot (v11.0, Systat Software Inc., Chicago, 
IL). 
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4 Chapter 4 – Results 
4.1 Descriptive Statistics 
Twelve hypertensive adults participated in this study. Table 4-1 displays the subject 
demographic, anthropometric, and hemodynamic data stratified by group. Data are 
presented as group means and by intervention group (IHG vs CON). No significant 
differences were identified between IHG and CON groups for demographic and 
hemodynamic variables (p>0.05; all). Although not statistically significant (p=0.096), 
members of the CON group (70 ± 5.7 years) were slightly older than were those of the IHG 
group (61 ± 9.6 years). Moreover, there were no significant differences between groups for 
education levels or medication usage (p>0.05; all). 
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Table 4.1 Subject demographics, anthropometrics, and education history 
  Group (n = 12) IHG (n = 8) CON (n = 4) p 
Female, n (%) 5 (42) 3 (37) 2 (50) 1.000 
Age, yrs 64 ± 9.5 61 ± 9.6 70 ± 5.7 0.096 
Height, m 1.68 ±0.10 1.69 ± 0.12 1.66 ± 0.05 0.573 
Body mass, kg 83.1 ± 14.7 87.4 ± 16.5 74.4 ± 3.6 0.158 
BMI, kg/m2 29.3 ± 3.56 30.3 ± 3.54 27.1 ± 2.91 0.160 
WHR 0.95 ± 0.06 0.95 ± 0.07 0.96 ± 0.06 0.833 
     
SBP, mmHg 132 ± 9 132 ± 11 133 ± 9 0.869 
DBP, mmHg 81 ± 10 85 ± 9 76 ± 8 0.134 
PP, mmHg 51 ± 10 47 ± 9 57 ± 13 0.155 
     
Education level  %   
High-school 42 37.5 50 0.576 
College 0 0 0 1.000 
University 25 25 25 0.764 
Post-graduate 33 37.5 25  0.594 
     
Medications    %   
ACE inhibitor 42 50 25 0.424 
Diuretic 42 50 25 0.594 
β-Blocker 58 63 50 0.576 
Ca+2 Channel Blocker 25 25 25 1.000 
Angiotensin receptor 
blocker 8 0 25 0.764 
α-2 receptor agonist 8 13 0 0.667 
α-1 receptor agonist 8 13 0 0.667 
Vasodilators 8 13 0 0.667 
Statin 58 75 25 0.152 
Aspirin 58 50 75 0.594 
Values are means ± SD. Independent samples t-tests were used on all continuous variables and 
Fisher’s exact tests were used on categorical variables.  
BMI, Body mass index; WHR, Waist-to-hip ratio; SBP, Systolic blood pressure; DBP, 
Diastolic blood pressure; PP, Brachial pulse pressure. 
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4.2 Baseline Cardiovascular and Cognitive Characteristics 
Baseline between group differences in cardiovascular (Table 4.2) and cognitive (Table 4.3) 
variables were assessed. One participant from the IHG group was removed from autonomic 
analysis as an outlier and one from ctPWV due to equipment malfunctioning. No 
statistically significant differences were identified for any cardiovascular or cognitive 
variable (p>0.05; all). 
Table 4.2 Baseline Cardiovascular characteristics      
  n IHG n CON p 
Dd, cm 8 6.92 ± 0.60 4 7.51 ± 1.27 0.292 
Ds, cm 8 7.32 ± 0.57 4 7.77 ± 1.47 0.588 
CCA PP, mmHg 8 22.5 ± 6.3 4 20.5 ± 6.1 0.609 
Distensibility, mmHg-1 x 10-3 8 5.55 ± 1.97 4 3.07 ± 1.94 0.066 
IMT, mm 8 0.426 ± 0.145 4 0.547 ± 0.096 0.167 
crPWV, m/s 8 8.91 ± 1.19 4 8.26 ± 1.58 0.445 
ctPWV, m/s 7 6.99 ± 0.62 4 6.54 ± 0.30 0.207 
cvBRS, ms/mmHg 7 6.23 ± 2.59 4 9.12 ± 3.29 0.140 
LF HRV 7 330 ± 278 4 833 ± 961 0.376 
HF HRV 7 149 ± 99 4 844 ± 1404 0.395 
LF/HF 7 2.05 ± 0.708 4 2.17 ± 1.10 0.822 
Values are means (±SD). Independent samples t-tests were used. Dd, Diastolic diameter; Ds, Systolic 
diameter; IMT, Intima media thickness; PP, CCA pulse pressure; cvBRS, Cardiovagal baroreflex 
sensitivity; LF-HRV, Low-frequency heart rate variability; HF-HRV, High-frequency heart rate 
variability; LF/HF, Ratio of low to high-frequency heart rate variability; ctPWV, Carotid-toe pulse wave 
velocity; crPWV, Carotid-radial pulse wave velocity. 
 
 
Table 4.3 Baseline Cognitive Characteristics 
  n IHG n CON p 
TMT-A, sec 8 25.9 ± 6.9 4 23.3 ± 6.7 0.547 
TMT-B, sec 8 65.8 ± 34.5 4 74.34 ± 32.7 0.690 
TMT-BA, sec 8 39.8 ± 28.9 4 51.04 ± 31.4 0.553 
TMT-B/A 8 2.4 ± 0.80 4 3.3 ± 1.6 0.342 
COWAT, total 8 43.7 ± 9.5 4 43.75 ± 20.0 1.00 
Values are means (±SD). Independent samples t-tests were used. TMT-A, Trail-making test part A; 
TMT-B, Trail-making test part B; TMT-BA, Trail-making test B minus A; TMT-B/A, Ratio of TMT-B 
divided by TMT-A, COWAT, Controlled oral word association task. 
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4.3 Cardiovascular Responses to IHG Training 
Figures 4.1 A-D show that the absolute changes in SBP, DBP, ctPWV, and BRS. SBP and 
ctPWV were significantly reduced in the IHG group in comparison to the CON group 
(p<0.05, all). Table 4.2 provides a complete summary of the change in all cardiovascular 
variables including SBP, DBP, and PP between IHG and CON groups from pre- to post-
testing sessions. Although not statistically significant, the IHG group demonstrated an 
increase in cvBRS (3.24 ± 3.30) compared to the CON group (0.59 ± 5.25), which equated 
to an ~53% increase from baseline. 
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Figures 4.1 A-D. Effects of 8 weeks of IHG training on (A) SBP, (B) DBP, (C) ctPWV, and (D) cvBRS. 
Independent samples t-tests were employed to test the difference in absolute change between IHG and CON 
groups. Bars represent group means and error bars represent SD. 
*indicates p<0.05. 
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Table 4.4 Cardiovascular changes following IHG training and control periods 
  IHG CON p 
ΔSBP, mmHg -4.5 ± 2.9 0.8 ± 5.4 0.049 
ΔDBP, mmHg -3.9 ± 5.7 1.8 ± 4.6 0.120 
ΔPP, mmHg -0.63 ± 5.60 -1.00 ± 6.48 0.919 
ΔDd, cm -0.01 ± 0.04 -0.01 ± 0.03 0.511 
ΔDs, cm -0.01 ± 0.05 0.01 ± 0.03 0.952 
ΔCCA PP, mmHg -1.9 ± 6.9 2.8 ± 3.3  0.237  
ΔIMT, mm 0.27 ± 0.42 -0.17 ± 0.31 0.089 
ΔDistensibility, mmHg-1 x 
10-3 0.26 ± 0.77 1.34 ± 2.03 0.203 
ΔctPWV, m/s -0.34 ± 0.33 0.24 ± 0.47 0.040 
ΔcrPWV, m/s -0.48 ± 1.26 0.11 ± 1.11 0.446 
ΔcvBRS, ms/mmHg 3.24 ± 3.30 0.59 ± 5.25 0.325 
ΔLF-HRV 588 ± 680 1073 ± 2060 0.676 
ΔHF-HRV 240 ± 341 -280 ± 1490 0.382 
ΔLF/HF 1.05 ± 1.60 1.77 ± 1.10 0.447 
Values mean ± SD. Independent samples t-tests were used on all change variables. Dd, Diastolic diameter; 
Ds, Systolic diameter; IMT, Intima media thickness; PP, pulse pressure; ctPWV, Carotid-toe pulse wave 
velocity; crPWV, Carotid-radial pulse wave velocity; cvBRS, Cardiovagal baroreflex sensitivity; LF-HRV, 
Low-frequency heart rate variability; HF-HRV, High-frequency heart rate variability; LF/HF, Ratio of low 
to high-frequency heart rate variability. 
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4.4 Cognitive Responses to IHG Training 
Figure 4.2 represents the absolute change in TMT-A score for the IHG and CON groups. 
A significant (p<0.001) decrease in TMT-A score was identified with the IHG group 
demonstrating a 3.65 ± 3.40 second reduction in time to completion when compared against 
the CON group. Furthermore, Table 4.3 provides a summary of the remaining cognitive 
outcome variables collected in this study. Both groups demonstrated non-significant 
reductions in TMT-B, TMT-BA, TMT-B/A  (all p>0.05); indicating that IHG training had 
no effect on these assessments of cognitive function. 
 
 
 
 
 
 
Figure 4.2. Effects of 8 weeks of IHG training on Trail Making Test Part A (TMT-A) score. Independent 
samples t-tests were employed to test the difference in absolute change between IHG and CON groups. 
Bars represent group means and error bars represent SD. 
**indicates p<0.001 
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Table 4.5 Cognitive adaptations following IHG training and control periods 
  IHG CON p 
ΔTMT-A, sec -3.6 ± 3.4 7.92 ± 5.0 <0.001 
ΔTMT-B, sec -18.9 ± 25.2 -12.2 ± 15.1 0.640 
ΔTMT-BA, sec -15.2 ± 25.1 -20.1 ± 17.9 0.737 
ΔTMT-B/A -0.27 ± 0.88 -1.37 ± 1.28 0.109 
ΔCOWAT, total -1.2 ± 6.2 0 ± 3.5 0.72 
ΔCES-D, score 0.75 ± 1.49 -0.50 ± 1.29 0.184 
Values mean ± SD. Independent samples t-test employed. TMT-A, Trail Making Test Part A; TMT-B, 
Trail Making Test Part B; TMT-AB, Trail Making Test Part B minus Part A; TMT-B/A, Trail Making Test 
Part B divided by Part A; COWAT, Controlled Oral Word Association Task; CES-D, Centre for 
Epidemiological Studies Depression Scale. 
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5 Chapter 5 – Discussion 
5.1 Introduction 
This study aimed to investigate whether 8-weeks of IHG training would have beneficial 
effects on measures of cardiovascular and cognitive health. These objectives were decided 
upon given a multitude of recent research outlined below. Although considerable evidence 
supports the beneficial effects of aerobic and dynamic resistance exercise on cognitive 
function, no study to date has examined whether isometric exercise can have a similar 
effect on cognitive function.167  
 There are several novel findings of the present study. This is the first study to 
identify a reduction in systemic arterial stiffness following IHG training as well, a trend 
towards increased cvBRS. Furthermore, this was the first IHG training study to examine 
changes in cognitive function, identifying increased motor and visual control and speed.  
5.2 Cardiovascular Adaptations: Mechanisms 
A significant reduction in SBP and a trend towards a reduction in DBP following 8-weeks 
of IHG training was observed in this study. No change in RRI (HR) was observed, in 
agreement with previous findings that HR is unaffected by IHG training.95,97,109,187–189 
Previously, studies have identified both reductions and no change in BP following IHG 
training in medicated hypertensive populations.19,95,98,101 However, there is considerable 
variability in the age, health status, and degree of BP control in the participants used in 
these studies. Taylor et al. identified substantial reductions in SBP and DBP in their sample 
of hypertensive adults demonstrating poor BP control, although 75% of the sample were 
treated for high BP. In comparison, our sample consisted of individuals with varying 
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degrees of BP control, from well to poorly controlled. This range may have resulted in the 
lack of a significantly observed change in DBP following IHG training.  
5.2.1 Regional Arterial Stiffness 
We identified a significant reduction in ctPWV in the IHG group following training. This 
is the first study to show systemic reductions in arterial stiffness following isometric 
training. It has been suggested that NO may be a key regulator of arterial stiffness in several 
clinical populations as its absence often results in increased central PWV.117 Previous IHG 
studies have mainly identified local adaptations in vascular function (i.e. increased brachial 
artery dilation following FMD) and have rarely examined the systemic effects of this 
exercise modality.187  
HR is a known confounder of PWV.190 As HR increases, so too does PWV such 
that if the same individual has a HR of 60 bpm vs 100 bpm, the average difference in 
cfPWV has been estimated at 1.36 ± 2.9 m/s.190 Of importance when considering the results 
of our study, we did not observe a significant change in HR following IHG training, thus 
it is unlikely that change in HR played a significant role in the reduction of ctPWV. It is 
possible that various phases of the cardiac cycle may have been altered following IHG 
training and thus contribute towards the reduction in ctPWV observed.191 It has previously 
been shown that the pre-ejection period of the cardiac cycle, not HR itself, may also 
confound PWV and should be investigated in greater detail, especially when examining 
PWV adaptations following IHG training.191 No IHG study has examined whether pre-
ejection period is affected by the training protocol. 
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Contrary to our initial hypothesis, we did not observe a reduction in upper-limb 
arterial stiffness (i.e. crPWV) with IHG training. This lack of change may be due to little 
or no change in sympathetic tone or catecholamine concentrations being insufficient to 
reduce PWV. The human ageing model shows that central arterial stiffness is more prone 
to increased levels of stiffness with advancing age than peripheral arterial stiffness (Figure 
2.1). This is in part due to the composition of the arterial walls in central and peripheral 
arteries and their ability to buffer pulsatile stress. We can hypothesize that the training 
stimulus used in this study may not have been of sufficient duration and/or intensity to 
elicit adaptations in resting peripheral arterial stiffness in hypertensive adults. Furthermore, 
without invasively assessing the arterial composition following IHG training, we cannot 
comment on alterations in arterial wall composition (i.e., collagen and elastin ratio).  
5.2.2 CCA Mechanical Properties 
CCA mechanical properties were unchanged following IHG training. A previous study 
identified improvements in femoral artery diameter, blood flow velocity and vascular 
conductance following isometric leg training in middle aged males.187 Similarly, following 
IHG training, increased brachial artery responsiveness to FMD has been identified, 
suggesting improved local vascular endothelium-dependent vasodilation.17,110 However, 
the CCA represents a hybrid arterial phenotype not entirely characteristic of the elastic 
central arteries and not of equal musculature to the peripheral arteries.49  
Lipsitz et al. have shown that aggressive anti-hypertensive therapy produces 
increased CCA distensibility and cerebral blood flow velocity in hypertensive adults.161 A 
treatment regimen consisting of Lisinopril with or without hydroclorothiazide, or 
nifedipine or an ARB, if not tolerated, to reduce SBP to <140 mmHg was used for 6 
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months.161 It was only in their uncontrolled hypertension group (160/84 ± 6/5 mmHg) that 
these changes were identified, whereas normotensive and controlled hypertensive groups 
exhibited no change in CCA distensibility.161 Our findings regarding CCA distensibility 
are in opposition to those of Lipsitz et al. likely due to disparities in BP status of treatment 
groups, intervention and participant age. Furthermore, our reductions in BP were modest 
in comparison to those of Lipsitz et al. (17 vs 4 mmHg) in part due to our relatively well-
controlled and younger sample. Thus, it remains a possibility that had the BP reduction 
been of a larger magnitude, we may have observed similar increases in CCA distensibility 
as Lipsitz et al.  
5.2.3 Autonomic Function 
Although we did not observe statistically significant improvements in cvBRS, the IHG 
training group demonstrated a ~53% increase in cvBRS. Previously, the only autonomic 
measure to have been assessed following IHG training was HRV and BPV, which has 
demonstrated mixed responsiveness.98,99,101,189 IHG training has been shown to improve 
traditional and non-traditional measures of HRV in some populations of hypertensive 
adults, as well as having no effect in others.97–99,101 It has been speculated this heterogeneity 
in autonomic response to IHG training may be due to pharmacological agents exerting a 
maximal effect on the threshold for autonomic improvement in medicated hypertensive 
populations. We demonstrated the first evidence that IHG training may have beneficial 
effects on cardiovagal baroreflex function. Importantly, the changes observed in this study 
surpassed the expected day-to-day variability of the measure (e.g. 13.5 – 35%).192,193  
 cvBRS is a clinically relevant measure of autonomic health, and low cvBRS is an 
independent risk factor for all-cause mortality following MI.68 Thus, a simple and effective 
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method of increasing cvBRS is warranted in order to reduce risk of adverse cardiovascular 
events in high-risk populations. Aerobic exercise is highly regarded for its ability to 
improve cardiovascular health, including cvBRS, yet requires a substantial time 
commitment in order to achieve the desired effects.194,195 IHG is well established at having 
a low-moderate acute BP response and involves a cardioprotective effect on the heart in 
comparison to aerobic exercise.15 Furthermore, the ability to perform the IHG training 
protocol utilized in this study requires minimal supervision and is shown to be effective in 
physically active and inactive populations of varying ages and health status.98,109,114 Thus, 
additional research should be undertaken to examine the effects of IHG training on cvBRS 
in other clinical populations whom may benefit from the improvements observed in 
cvBRS.  
5.3 Cognitive Adaptations 
This was the first study to investigate the influence of IHG training on cognitive function. 
Extensive literature indicates aerobic exercise has beneficial effects on cognitive function 
in many populations.126,195 Similarly, resistance exercise is also known to result in 
improvements in cognitive function.196 Isometric exercise produces similar health benefits 
to that of aerobic and resistance exercise, and requires a fraction of the time commitment. 
Thus, if isometric exercise can induce similar cognitive benefits as aerobic and resistance 
exercise, it may lead to potential intervention strategies which target attenuating cognitive 
decline or even enhancing cognitive function, especially in populations of lower fitness 
levels.  
 Significant improvements in time to completion of TMT-A in the IHG training 
group compared to the CON group were observed. This is indicative of increased motor 
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and visual control and speed, suggesting that IHG training improved this aspect of 
cognitive function independent of learning effects. It can be hypothesized that this 
adaptation was a result of several physiological interactions. The reduction in SBP and 
improvement in vascular health observed in our IHG group may be responsible for 
mediating the improvement observed in TMT-A score. Previous studies have concluded 
that individuals with poorer vascular health experience significant improvements in 
cognitive function following a period of intervention.169  
These improvements in TMT-A score may be a result of the reduction in SBP and 
arterial stiffness which buffers forward pulsatile stress into the cerebral vasculature. The 
relationship between large artery stiffness and pulsatile stress into the microvasculature of 
the brain is well documented, with researchers having shown aortic stiffness is an 
independent predictor of small vessel disease in hypertensive patients.154 Moreover, 
research to date has focussed on investigating the cross-sectional relationship between 
markers of large artery stiffness, cognition, and cerebral small-vessel damage, with few 
utilizing interventions which target reductions in arterial stiffness.  Of those who have, the 
interventions have involved drastic lifestyle alterations, which would be difficult to 
maintain outside of research settings and have been of similar duration to our study (8-16 
weeks).161,169 Although, our IHG training did result in modest improvements at the 
recommended training frequency and duration, the adaptations observed in our study and 
those of others may be enhanced with a longer intervention, as a longer intervention may 
allow for optimal effects. Whether maintaining IHG training over a prolonged period of 
time (i.e. >16 weeks) would result in greater and sustainable enhancements in cognitive 
function remains to be determined and should be a subject of future investigations.  
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 An alternative theory for the improved cognitive function observed in the current 
study may be due to changes in cerebral perfusion and the neurotransmitters glutamate and 
amyloid-β.126 As the brain requires a constant supply of blood flow to maintain homeostatic 
cognitive processes, certain factors contribute towards achieving this outcome. The brain 
accounts for 2% of the body’s mass but requires ~15% of CO.197 Cerebral hypoperfusion 
is known to result in increased release of glutamate, the most abundant excitatory 
neurotransmitter in the brain, and is crucial to memory and learning functions.198 
Furthermore, cerebral hypoperfusion results in harmful levels of glutamate and amyloid-β. 
Both may be due to low elasticity of central arteries as well as that of the CCA.126 As 
cerebral perfusion was not assessed in this study, it is unclear whether changes in CBF may 
have contributed towards the improvements in TMT-A score following IHG training. Nor 
was functional MRI assessed to determine whether local changes in CBF occurred during 
the task or at baseline. Thus, little is known regarding the possible reductions in glutamate 
and amyloid-β accumulation in the brain and how it may have influenced cognitive 
function in this sample. 
5.4 Strengths and Limitations  
The present study has several strengths. First, multiple cognitive assessments were utilized 
(i.e. TMT-A, TMT-B, COWAT, MoCA) instead of relying on a single assessment, thus 
allowing us to examine multiple indices of cognitive function.122,175,176 Secondly, measures 
were taken to limit the influence of learning effects on the TMT and COWAT respectively. 
For example, alternative TMT-A and TMT-B trails were developed for participants’ pre- 
and post- assessments based on previously established methods which cite no significant 
difference across test versions in trail length and time to completion.175 Alternate versions 
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of the COWAT were also used as is standard clinical order for CFL to be followed by 
PRW.177 Third, regarding cardiovascular measures, use of local arterial PP at the CCA is 
considered a strength as this approach enables accurate calculation of distensibility 
compared to using brachial PP which underestimate distensibility due to peripheral PP 
amplification.48 Fourth, although time of day for testing across study participants was not 
controlled (i.e. exclusively morning sessions), each individual reported for all laboratory 
based testing sessions within 1-2 hours of their initial laboratory testing start time. Fifth, 
all testing and analysis were performed by the same investigator using standardized 
laboratory procedures for each participant, thus limiting inter-observer variability. Lastly, 
all individuals in this study were on medication to manage their BP and at baseline were a 
relatively well controlled sample.  
This study does also possess several limitations. First, although not statistically 
different, the CON group age was greater than that of our IHG group. This may have 
confounded both cardiovascular and cognitive outcomes and comparisons between 
groups.14,143,147,151 Participants were enrolled in the study on the basis of contact with the 
study investigators and not specifically to fulfill age and sex-matched criterion. 
Additionally, assignment into study groups was not done at random due to the continuous 
enrollment of participants into the study and not knowing the total number of individuals 
whom would enroll. Second, aerobic fitness was not assessed and thus it cannot be ruled 
out that some individuals may have been of greater aerobic fitness level than others which 
could have confounded both cardiovascular and cognitive outcomes.126,167 However, 
participants were instructed to maintain consistent diet and exercise habits during the 8-
weeks of the study and study investigators verbally assessed this consistency on a weekly 
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basis. Third, although it was an initial goal of this study to utilize cfPWV as the main 
measure of central arterial stiffness, we were only able to obtain valid femoral pulse wave 
signals via applanation tonometry on a small portion of participants (n=3) due to participant 
non-compliance (did not wear proper attire or did not feel comfortable with the 
measurement site) in order to obtain the femoral pulse. ctPWV was instead used as an index 
of central arterial stiffness which has been shown to closely correlate to cfPWV and 
displays similar test-retest variability to cfPWV.181 Fourth, central adiposity may have 
resulted in increased measurement distance used in the calculation of PWV; ultimately 
resulting in a lower PWV value.48 Fifth, blinding strategies were not employed in this study 
for either the participants or investigators. Therefore expectation bias may have influenced 
our results.  
5.5 Future Directions 
Considering the current findings, several future topics should be investigated. This study 
did not investigate possible changes in MSNA. It has previously been shown that MSNA 
is unaffected by IHG training in young adults; whether MSNA is improved in hypertensive 
populations following an IHG training protocol similar to that utilized in the present study 
has not yet been investigated.96 It is known that hypertensive populations demonstrate 
increased sympathetic discharge during isometric exercise compared with normotensive 
populations.107 These exaggerated sympathetic and pressor responses exist following a 
period of post-exercise ischemia, suggesting an overactive metabolic component of the 
pressor reflex in hypertensive individuals.199 In a normotensive population, isometric 
endurance exercise attenuates the MSNA response to an endurance isometric 
contraction.200 However the chronic exposure of forearm vasculature to by-products of 
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anaerobic metabolism during IHG training may augment this pressor response and result 
in attenuated MSNA responses to isometric exercise in hypertensive populations.199 For 
this reason, in future studies, MSNA and cvBRS should be investigated concurrently in 
hypertensive populations. 
Similarly, a study which utilizes aerobic + IHG, or resistance + IHG to compare 
whether IHG exerts an additive effect on cardiovascular health has not been conducted. 
One merit to IHG exercise is that it is simple and time-efficient to perform, thus making it 
a perfect adjunct therapy to aerobic or resistance exercise. High aerobic fitness is associated 
with higher cognitive function in addition to preservation of cognitive function over follow-
up.126,167,201 It has previously been determined that IHG is able to reduce BP in healthy 
individuals who participate in regular physical activity.17,98,114,188 However, the physical 
activity in question was of an unknown type, duration, intensity, and frequency and VO2 
was not assessed in any study involving IHG. Thus, whether a combined aerobic + IHG or 
resistance + IHG training regimen can provide increased cognitive adaptations compared 
to each individually may be a research area to be explored in future studies.  
Furthermore, future studies should consider the long-term (e.g. 12-weeks to 6 months) 
effects of IHG training on cognitive function. Our IHG training period was 8-weeks in 
duration, which may have been too short to identify noticeable effects on cognition. A 2010 
study on dietary approaches to stop hypertension demonstrated in a 16-week period that 
participants of poorer cardiovascular health were more likely to see improvements in 
cognitive function following their intervention.169 These improvements were however 
mediated by weight loss, increased aerobic fitness and to some extent a reduction in SBP.169 
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Thus, lengthening the intervention period and/or increasing the training intensity may 
result in more substantial adaptations in cognitive function following IHG training.  
This was the first study, to our knowledge, to investigate the effects of IHG training 
on cognitive function in any population. Our study was effectively powered to detect 
significant change in SBP and as such, the cognitive adaptations were not factored into 
power calculations. Knowing the magnitude of change in cognitive variables from this 
study, future studies can effectively be powered to detect similar changes of these 
magnitudes in their samples in order to better establish the effects of IHG training on 
cognitive function. Secondly, although attempts were made to reduce the likelihood of 
learning effects in the current study and to provide alternate versions for retesting purposes, 
future studies may consider utilizing more sensitive cognitive tests designed to detect small 
changes in cognition. The TMT and COWAT were selected for this study due to their 
prevalence in the literature and for the availability of multiple testing forms.175,176 
Additionally, in order to draw direct comparisons between changes in the current sample 
and those of other studies, the TMT and COWAT were selected. For example, a commonly 
used test of executive function, specifically cognitive inhibition and shifting cognitive set, 
is the Stroop Colour-Word Task. Providing a more widely used assessment of executive 
function with numerous variations may allow for future research in isometric exercise 
training studies on cognitive function to track changes over a longer period of time and 
detect smaller differences. 
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5.6 Conclusions 
This study aimed to investigate the effects of 8-weeks of IHG training on cardiovascular 
and cognitive health in hypertensive adults. Previous research indicates that chronic IHG 
exercise has beneficial effects on local vasculature in the trained limbs of medicated 
hypertensives but fails to exert a systemic effect on vasculature unrelated to the 
intervention/exercising limbs.115,187 Researchers have consistently shown the association 
between high BP and cognitive decline later in life as well as lower cognitive function 
when compared against age-matched normotensive adults.8,9,11,14 These same researchers 
suggest investigating methods designed towards improving both cardiovascular and 
cognitive health in these populations to attenuate both the adverse effects of hypertension. 
One such intervention which could achieve both adaptations is IHG training which we 
hypothesized would improve a number of factors associated with poor cognitive function 
such as BP, arterial stiffness, and BRS. The beneficial effects of aerobic and more recently 
resistance exercise training on cardiovascular and cognitive health are well acknowledged 
in research settings.167 These studies generally find regular exercise leads to improvements 
in cognition as well as attenuated rates of cognitive decline.126,169 Yet, no study has 
investigated whether the much less time consuming and equally effective IHG training can 
result in similar or greater improvements in cardiovascular and cognitive health than 
aerobic, resistance, and even pharmacological methods. The current study utilized an 8-
week IHG exercise training study consisting of 3 days/week training, 2 days of which were 
supervised, in hypertensive adults. Each training session involved bilateral handgrip 
training held at 30% MVC for 2 minutes for a total of 4 sets separated by 1 minute, 
alternating hands after each contraction. All participants completed all training days and 
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achieved the minimum required compliance score (90%) which indicates a successful 
training session.  
Significant reductions in SBP, ctPWV, and TMT-A score following 8-weeks of 
IHG training in hypertensive adults were observed. There was a failure to observe changes 
in CCA distensibility and diameters following training. Moreover, the expected change in 
crPWV was not observed, perhaps due to the predominantly muscular composition of 
peripheral arteries. The lack of change in CCA distensibility and diameters is in agreement 
with previous literature investigating the effects of isometric exercise on arterial structure 
and function not localized to the training limb.187 Additionally, a 53% increase in cvBRS 
was observed, although it failed to reach statistical significance in our study. This is the 
first study to observe systemic reductions in arterial stiffness as well as improvements in 
cognitive function following isometric exercise training. Future research should consider 
the combined effects of aerobic + IHG or resistance + IHG exercise on cognitive health to 
determine if there is an additive effect. Additionally, future investigations should focus on 
the effects of long-term IHG training on PWV, cvBRS, and cognitive function as well as  
introduce measures such as CBF and structural alterations in the brain for a more 
comprehensive understanding of the potential benefits of IHG training.  
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Appendix A 
INFORMATION LETTER 
 
You have been invited to take part in a research study. This letter will outline the purpose 
of the project, describe the procedures that are required, tell you about potential risks and 
benefits to yourself, and discuss your rights and confidentiality issues. If you wish to 
participate, you will be asked to sign a consent form at the end of this letter. Feel free to 
ask any questions you might have at any time. 
 
Study Title: 
Influence of Isometric Handgrip Exercise Training on Cardiovascular and 
Cognitive Health in Hypertension 
 
Researchers and Contact Information: 
Deborah O'Leary, PhD phone: 905-688-5550 ext 4339     e-mail: doleary@brocku.ca 
Kylie Dempster, BSc phone: 905-688-5550 ext 4593     e-mail: kd10dx@brocku.ca 
Dept of Health Science, Faculty of Applied Health Sciences, Brock University, St 
Catharines, ON, L2S 3A1. Brock Niagara Centre for Health and Well-Being, 130 
Lockhart Drive, St Catharines, ON, L2T 1W5. 
Matt Greenway, MD, PhD phone:  905-685-6555  email: 
greenwam@mcmaster.ca 
Garden City Family Health Team, Montebello Medical Centre, 118 Lake Street, St 
Catharines, ON, L2R 5Y1. 
 
Collaborators 
Cheri McGowan, PhD phone: 519-253-3000 ext. 2451    e-mail: 
mcgowanc@uwindsor.ca 
 
What is the purpose of this study? 
In Canada, 1 in 5 people have high blood pressure, or resting blood pressure numbers that 
are ≥ 140/90 mmHg. In addition, high blood pressure has been linked to lower cognition 
and faster rates of cognitive decline as you age. 
 
High blood pressure is commonly associated with greater stiffness of the large arteries and 
a poorer ability to manage both short and long-term blood pressure. Exposure to high blood 
pressure over a long period of time (i.e. several years) may lead to worse cardiovascular 
health and potential impairments in cognitive function.  
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A new blood pressure management therapy, isometric (constant squeeze) handgrip exercise 
training lowers resting blood pressure in people with high blood pressure, and even those 
with well-controlled blood pressure. Squeezing a small handgrip device for 2 minutes, 4 
times, 3 days per week for 8 to 10 weeks is now suggested by the American Heart 
Association as a way to lower blood pressure. This study will look at how this type of 
exercise affects your blood pressure and the stiffness of your arteries. It also aims to 
investigate the relationship that blood pressure has with your cognitive health and whether 
this can be improved as a result of the exercise training. 
 
Am I eligible? 
This study focuses on men and women diagnosed with high blood pressure who are on a 
consistent medical regimen.  
Study Inclusion Criteria 
 Currently taking medicine prescribed to lower your blood pressure 
Study Exclusion Criteria 
 Any hospitalization within the past 3 months 
 Change in medication within 2 months or over the course of the intervention period 
 Physical limitation preventing proper performance of handgrip exercise 
 
 
What are the procedures? Will there be any risk involved? 
Preliminary procedures: 
If you volunteer to participate in this study, you will be asked to attend the following: 
 
Visit #1 (approximately 30 minutes): 
You will meet with the study investigators at the Brock-Niagara Centre for Health and 
Well-Being where you will receive information and consent forms regarding the study. At 
this time, one of the study investigators will explain all parts of the study, if you are still 
interested in participating, you will be asked to sign the consent form and fill out a brief 
medical questionnaire. If you are still eligible, you will then have your blood pressure 
measured on your upper arm, similar to how it is taken in a doctor's office. Your resting 
blood pressure and heart rate will be measured after 10 minutes of seated rest and repeated 
4 times, with 2-minutes of rest between measures. Following the above procedures, your 
second visit will be scheduled. 
 
Visit #2 (approximately 40-50 minutes): 
If you are still interested in participating in the study, and you are initially eligible after 
Visit #1, you will meet with the investigators again. First, you will have your resting blood 
pressure measured in the same manner as Visit #1. You will then practice all parts of the 
study, including performing the handgrip exercise (four 2 minute squeezes, separated by 1 
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minute of rest, and alternating hands after each squeeze). You and the study investigators 
will then schedule your first laboratory testing day. 
 
Laboratory Testing Days (approximately 2-3 hours): 
All laboratory testing will take place at the same time of day, in a quiet room located at 
Brock University in Welch Hall room #22. In total, you will be required to come into the 
laboratory on 3 occasions throughout the study: Week 0, Week 9, and Week 12. Before 
each testing session, you will be asked to go to the washroom, as a full bladder can increase 
your blood pressure. All the procedures involved in the laboratory testing are listed below: 
 
Body Measurements which include your height, weight, and waist and hip circumferences 
will be measured. 
 
Heart Rate will be monitored by an electrocardiogram. Two sets of disposable, single-use 
electrodes will be placed just below each collar bone and on the lower left side near your 
ribs. There is a very small chance that you might develop a skin rash from the adhesive on 
the electrodes, but there is no way of knowing if you will be sensitive ahead of time. If a 
rash develops, the investigators can provide hypoallergenic gel. 
 
Blood Pressure will be measured using two methods. In addition to the traditional method 
which involves the arm cuff and stethoscope, a small cuff will be wrapped around the 
middle finger on your left hand. This cuff will apply a light pressure around the finger, 
which allows us to measure the blood pressure for each heart beat throughout the study. 
You should not feel any discomfort. A heating pad might be used to keep your hand warm 
throughout the test. 
 
Blood Vessel Imaging will be performed using ultrasound. The investigator will gently 
hold the ultrasound tool against the skin at the front of your neck while they take several 
pictures of two of the main blood vessels that lead to the brain (1 on the front region of 
your neck, and 1 slightly closer to the jaw line). This technique is similar to what is used 
in hospitals to investigate the heart and blood vessels or to look at a baby during pregnancy. 
Ultrasound monitoring requires the use of water-soluble, hypoallergenic gel between the 
probe and the surface of the skin. 
 
Arterial Stiffness will be measured using a small pressure pen held against the skin at 
several locations including the wrist, neck (1 near the middle of the neck and 1 closer 
towards your jawline), and groin. In addition, a small toe-clip will be placed on your left 
second toe.  
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Cognitive testing will involve several paper and pencil tasks conducted by the study 
investigator. For example, you will be asked to remember a list of words, draw objects, 
trace a trail on paper, and make decisions to solve problems. Some tasks are easy while 
others are more difficult. It is important to try your best, no matter how easy or challenging 
you may find them. It is possible that you may feel some anxiety around completing these 
tests; however you will have the opportunity to practice before hand and ask any questions 
you may have. 
 
24 hour Ambulatory Blood Pressure Monitoring device will be sent home with you 
following your three laboratory testing sessions. This device will periodically inflate on 
your arm for a period of 24 hours during which time you are encouraged to go about your 
normal activities of daily living and avoid strenuous physical activity. The monitor will 
automatically inflate once every 30 minutes during the day-time and every hour at night-
time.  
 
 
Are there any special instructions I should follow when I come in to the lab? 
Yes. On each day of laboratory testing, you are asked to: 
 Not perform any strenuous physical activity for 24 hours prior to the laboratory 
sessions 
 Avoid caffeine, alcohol, and nicotine on the day of testing 
 Eat only a light meal at least 4 hours prior to the start of testing 
 Bring with you a loose-fitting short sleeve shirt and shorts 
 
You will be reminded before each laboratory testing of the requirements listed above. 
 
Handgrip Training days (approximately 20 minutes): 
Following the initial Laboratory Testing day, you will be randomly (by chance) allocated 
to be in 1 of 3 groups. Groups 1 and 2 will be asked to perform 3 handgrip exercise sessions 
per week, identical to the exercise performed during Visit 2 (four 2 minute squeezes, 
separated by 1 minute of rest, and alternating hands after each squeeze). Again, these will 
be performed at 30% of your hardest squeeze on each training day. Two out of 3 weekly 
training days will be performed at the Brock-Niagara Centre for Health and Well-Being or 
Brock University campus, while the remaining training day may be performed at home. On 
supervised exercise session days, your blood pressure and heart rate will be monitored 
before each session, and handgrip exercise will be supervised by an exercise trainer. 
 
If you are in Group 3, you will still visit the centre twice each week to have your blood 
pressure and heart rate measured. In all groups we will monitor any changes in diet, 
exercise, and medication on a log sheet which will be provided to each participant and ask 
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that you sign the log at each visit to demonstrate that you still would like to be involved in 
the study.  
 
Isometric handgrip exercise may result in some tendon soreness of the exercising limb. 
Measures are in place which minimize the likelihood of this happening such as alternating 
hands which perform the contractions. This training protocol has been approved by the 
American Heart Association and is shown to produce minimal increases in heart rate and 
blood pressure, even in hypertensive populations. These increases go away quickly and 
pose no health risk to you. If you experience an adverse reaction, emergency action plans 
are set in place and all researchers and assistant will be trained to safely handle the situation. 
 
At the end of the 8 weeks of training (Groups 1 and 2), you will perform handgrip exercise 
for another 4 weeks. During the final 4 weeks of handgrip training, the number of sessions 
that you are required to perform each week may remain the same (3 sessions per week) or 
you may stop the exercise altogether. You will be notified how many sessions you will be 
required to complete. Each week, your resting and ambulatory blood pressure will be 
monitored. Finally, at the end of the final 4 week period, you will have a final testing day 
at Brock University (Welch Hall, room #22) followed by 24 hour ambulatory blood 
pressure measurement. 
 
 
Will I benefit from this study? 
You may or may not experience a lower blood pressure at rest or during your activities of 
daily living after each part of the study. If handgrip training lowers blood pressure in the 
people in this study, it may be used by other individuals if their blood pressure is higher 
than it should be despite taking multiple blood pressure medications.  
 
The handgrip training may result in improved arterial stiffness, short and long-term blood 
pressure regulation, and cognitive function. While these potential improvements may not 
be noticeable to you in your daily life, they have a large impact on your cardiovascular 
health over time. 
 
You will be provided with feedback concerning the average responses of all participants 
as soon as possible following the completion of the study. A full summary of the study can 
be made available to all participants within 8 to 10 months following the conclusion of the 
testing period. 
 
Will I be rewarded for volunteering my time? 
You will be provided with free parking on Brock University premises during all laboratory 
based testing sessions. Secondary monetary compensation will not be provided. 
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Can I withdraw from the study? 
Yes. Your participation in this study is completely voluntary. You may withdraw from 
the study without penalty or any consequences at any time by making the researchers 
aware of your decision. Should you choose to withdraw, the confidentiality of your 
involvement in the study will be maintained and  data will be confidentially destroyed. If 
you do choose to withdraw, in most cases we will ask to use any data collected up to the 
time of your withdrawal, but you can request that any and all of your data be destroyed, 
again without consequence.  
 
Your participation, or lack thereof, in this study will in no way influence your ability to 
participate in future studies at the Brock-Niagara Centre for Health and Well-Being or 
Brock University. The investigators may withdraw you from this research if circumstances 
arise which warrant doing so. Typically, this may occur due to change in medication, 
nutrition, or physical activity status. 
 
 
How confidential and secure is my personal information? 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will not be disclosed at any point in time without 
your expressed permission. Data will be retained for a period of 5 years following the 
completion of this study.  
 
To ensure full confidentiality, following your consent, you will be assigned an 
identification code that can only be linked back to your data by an assigned study 
investigator. When the data are published in scientific journals or presented at research 
conferences, they will be expressed as group averages. In the event that individual data will 
be highlighted, the identification of that person will not be revealed. All paper data will be 
stored in a locked laboratory cabinet in Welch Hall at Brock University only accessible by 
study investigators. Digital information will be password protected. All information 
including medical questionnaires which contain personal identifiers will be destroyed if 
you choose to withdraw from the study. 
 
Has this study received ethics clearance? 
This project has been reviewed and received ethics clearance through the Brock University 
Bioscience Research Ethics Board (15 - 065). 
 
We would like to remind you that if you have any questions, you may contact us at any 
time. Our contact information is on the first and last pages of this letter. Thank you for 
considering our study. 
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Sincerely, 
 
Dr. Deborah O'Leary and Kylie Dempster 
Department of Health Sciences, Brock University 
905-688-5550 ext. 4339 
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Appendix B 
CONSENT FORM 
Study Title: 
Influence of Isometric Handgrip Exercise Training on Cardiovascular and 
Cognitive Health in Hypertension 
 
Researchers and Contact Information: 
Deborah O'Leary, PhD phone: 905-688-5550 ext 4339     e-mail: doleary@brocku.ca 
Kylie Dempster, BSc phone: 905-688-5550 ext 4593     e-mail: kd10dx@brocku.ca 
Dept of Health Science, Faculty of Applied Health Sciences, Brock University, St 
Catharines, ON, L2S 3A1.Brock Niagara Centre for Health and Well-Being, 130 Lockhart 
Drive, St Catharines, ON, L2T 1W5. 
 
Collaborators 
Cheri McGowan, PhD phone: 519-253-3000 ext. 2451    e-mail: 
mcgowanc@uwindsor.ca 
 
Your participation will remain confidential. The personal data collected from this 
investigation will be kept secured on the premises of Brock University in Dr. O’Leary’s 
office or laboratory, and will not be accessed by anyone other than the listed investigators. 
Investigators will require disclosure of your name and contact information (phone, email), 
and therefore your participation is not anonymous during the conduct of the research. 
However, all participants will have their names removed from any data. The master list 
matching participants to data will be kept by Kylie Dempster (student PI) in a secured 
room.  
I have read the information presented in the information letter about the procedures and 
risks involved in this study. I have had the opportunity to ask any questions related to the 
study and have received satisfactory answers. I am aware that I may withdraw from the 
study without penalty at any time by making the researchers aware of this decision. If I 
have any further questions about participation in this study I know that I may contact Kylie 
Dempster, BSc, by phone at 905-688-5550 ext 4593, or by e-mail at kd10dx@brocku.ca or 
Deborah O'Leary, PhD, by phone at 905-688-5550, ext. 4339, or by e-mail at 
doleary@brocku.ca. 
With full knowledge I agree, on my own free will, to be a participant in the research project 
identified above. I am aware that by signing the consent form, I am not waiving my legal 
rights or releasing the investigator(s) or involved institution(s) from their legal and 
professional responsibilities. 
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____________________________  ____________________________ 
Participant (print name)   Participant (signature) 
 
____________________________  ____________________________ 
Witness (print name)    Witness (signature) 
 
____________________________  ____________________________ 
Date      Location 
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Appendix C 
Medical and Educational History Questionnaire 
Personal Information: 
Height:_______ Weight:_______  Date of Birth:______________ Ethnicity:______ Sex: 
M / F 
Phone: (___)_________ Postal Code:__________ 
Emergency Contact Information: 
Name:________________ Relation:___________ 
Address:______________________________________________
 Phone:(___)_____________ 
Medical Background: 
Please circle Yes or No for each of the following questions:     
  
1. Have you ever been hospitalized?       Yes   No 
If yes, please 
specify.______________________________________________________ 
Have you ever had surgery?      Yes   No 
If yes, please specify. 
______________________________________________________ 
 
2. Are you presently taking any medications or pills (including aspirin, and other 
over the counter medications)?      
 Yes   No 
If yes, please specify. 
______________________________________________________ 
 
Medication name Dose Frequency 
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Are you presently taking any vitamins, supplements, and/or herbal supplements? 
Yes No 
 
3. Do you have any allergies (medicine, food, bees)?      Yes  No 
If yes, please specify. 
______________________________________________________ 
 
4. Have you ever passed out during or after exercise?    Yes No 
Have you ever been dizzy during or after exercise?   Yes No 
Have you ever had chest pain during or after exercise?   Yes No 
Do you have high blood pressure (hypertension) or low blood pressure 
(hypotension)?          
 Yes No 
Have you ever been told that you have a kidney problem?   Yes No 
Have you ever been told that you have joint instability?   Yes No 
Have you ever been told that you have a stomach problem?  Yes No 
Have you ever been told that you have a heart problem?   Yes No 
Have you ever been told that you have a heart murmur?   Yes No 
Do you have a machine that regulates your heart rate (pacemaker)? Yes No 
Have you ever had racing of your heart or skipped beats?  Yes No 
Has anyone in your family died of heart disease or sudden death before age 50?  
         Yes No 
 
5. Do you have Diabetes?      Yes No 
 
6. Do you have asthma or any other breathing related problems?  Yes No 
If yes, please specify: 
______________________________________________________ 
 
7. Do you have any type of cardiovascular disease?   Yes No 
If yes, please specify: 
______________________________________________________ 
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8. Have you had any other medical problems?     Yes No 
If yes, please specify: 
______________________________________________________ 
 
9. Have you had any medical problems since your last physical examination? Yes
 No 
 
10. Do you currently smoke?       Yes No 
Have you ever smoked?      Yes No 
If yes, specify date of smoking cessation: 
______________________________________ 
 
11. Do you exercise >30 minutes on ≥2 days per week?   Yes No 
If yes, please describe your activities 
_________________________________________ 
 
Exercise Duration (mins) Frequency Intensity 
    
    
    
    
    
    
    
 
12. Are you currently pre-, peri-, or post-menopausal? (Answer post-menopausal if 
your last menstrual period was over one year ago). Please circle the most 
appropriate response.  
Pre-menopausal  Peri-menopausal  Post-menopausal 
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13. If post-menopausal, at what age did you consider yourself menopausal? 
__________________________________________________________________
______ 
 
14. Did you in the past, or do you currently take hormone replacement therapy? 
Yes I am currently on HRT 
Yes I have taken HRT but do not currently 
No I have never taken HRT 
 
Educational Background: 
Please circle the highest educational ranking achieved: 
a) High School Diploma 
b) College Degree (2 years) 
c) University Degree (4 years) 
d) Graduate Degree (Master's and/or Doctorate) 
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Appendix D 
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Appendix E 
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Appendix F 
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Appendix G 
Centre for Epidemiological Studies Depression Scale 
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Appendix H 
Power Calculation 
Statistical power was calculated to detect a significant change in SBP following IHG 
training according to a recent review specifically examining cardiovascular adaptations to 
IHG training.15 SBP was selected due to its consistent association with arterial stiffness, 
BRS, and cognitive function.7,14,76 This review identified average adaptations to IHG 
training across all studies to be approximately 10-13 mmHg, depending on the population 
selected.15 As we were interested in hypertensive individuals who often experienced larger 
reductions in BP in response to IHG training, a difference of 13 mmHg was selected for 
our power calculation. Significance was set to α = 0.05 in order to calculate a required 
sample size for detecting the 13 mmHg difference in SBP for power values ranging from 
0.6 – 0.9. The results of this calculation are presented below. It was determined that a 
sample size of 8 participants in the IHG group would be required to achieve 80% power 
based upon previously established reports.  
Power Calculation     
Nominal Power Actual Power Sample size 
0.6 0.642 6 
0.7 0.741 7 
0.8 0.817 8 
0.9 0.913 10 
 
